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Background: Medical Male Circumcision (MMC) reduces the risk of HIV-1 acquisition 
by up to 60% as shown in a number of randomized controlled trials in Uganda, Kenya 
and South Africa. MMC has also been shown to reduce the prevalence of other 
sexually transmitted infections (STIs) like Herpes Simplex Virus (HSV) -2 and Human 
Papillomavirus (HPV) by 25% and 35% respectively.  Asymptomatic STIs may elevate 
the risk of HIV-1 acquisition by recruiting HIV-1 target cells to the foreskin. The higher 
permeability of the inner foreskin may play a role in HIV-1 acquisition as well as the 
number of target cells present in the foreskin. The more inflamed inner foreskin may 
be increasing the risk of a productive HIV-1 infection.  The aims of this dissertation 
was to a) examine the levels of keratinisation in the inner and outer foreskins after 
MMC; b) investigate the number of Langerhans, Ki67+ and CD4+ T cells in the inner 
and outer foreskin and c) identify the impact of asymptomatic STIs on the numbers 
and proliferative capacity of foreskin-resident Langerhans and CD4+ T cells. 
Methodology: A total of 150 young males (14-24 years) were recruited from Edendale 
Hospital in Kwa-Zulu Natal and the Perinatal HIV-1 Research Unit in Soweto, 
Johannesburg, South Africa. Foreskins, blood and urine were collected. Using 
immunofluorescent staining (IFS) of foreskin tissue sections, keratin thickness was 
measured and immune cells present in the inner and outer foreskin were 
characterised. We optimised the types and concentrations of collagenase, type of 
maceration and fresh versus frozen tissue for flow cytometry. Once techniques were 
optimized for IFS, we stained for CD4+, langerin+ (CD207) and Ki67+ cells as well as 
filaggrin for keratin thickness in a subset of 28 age-matched HIV-1 negative individuals 
(14 – 24 years) undergoing elective MMC. An average of 5 images per tissue was 
taken, keratin thickness and cell depth was measured and cell densities quantified 
using integrative data language (IDL). We compared all parameters between the inner 
and outer foreskin and assessed the impact of STIs (C. trachomatis, N. gonorrhoea, 
M. genitalium, T. vaginalis, HSV-1 & 2 and HPV) on HIV-1 target cell density and depth 





Results: Antibody dilutions for CD4, CCR5 and CD209 worked best at 1:100, 1:10 
and 1:200 respectively and the use of Alexa647 was best for the detection of Ki67. 
Immunofluorescent staining for CD4, Ki67 and CD207 to identify proliferating immune 
cells and filaggrin for keratin layers showed significantly higher numbers of CD207+ 
Langerhans cells present in men with STIs, in both the inner (3.3 vs 0.3 cells/mm2 in 
STI+ vs STI- men, p<0.0017) and the outer (4.4 vs 0.6 cells/mm2, p<0.0005) foreskin. 
There were no significant differences in CD4+ T cell (4.4 vs 2.7 cells/mm2 in the inner 
and outer foreskin) and Ki67 cell (3.8 vs 3.2 cells/mm2 in the inner and outer foreskin) 
counts regardless of STI status and the keratin layer was significantly thicker (8.3873 
vs 6.6748µm in outer vs inner foreskin, p=0.0058) with a median difference of 
1.712µm. LCs were significantly closer to the keratin layer (75.25 vs 99.19 µm in outer 
vs inner foreskin, p<0.0001) with a median difference of 23.922μm. LCs in the outer 
foreskin were significantly closer (68.19 vs 83.608µm of STI+ and STI- men, p=0.0385) 
to the keratin layer with a median difference of 15.418µm.  
Conclusion: This study successfully quantified HIV-1 target cells susceptible to 
infection present in the foreskin by using a formerly quantitative only method such as 
immunofluorescence. Lastly, the thicker keratin layer of the outer foreskin suggests 
that the level of keratinization provides a more robust barrier than the thinner keratin 
layer of the inner foreskin. Asymptomatic STI-induced inflammation and recruitment 
of immune cells may be elevating the risk of HIV-1 acquisition in uncircumcised men. 
Therefore, MMC removes the potential HIV-1 target cells present in foreskins of highly 
susceptible sexually active group of young adolescent uncircumcised men in South 
Africa and this in turn may lower the risk of acquiring an STI infection as well as reduce 
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Since the discovery of Acquired immunodeficiency syndrome (AIDS) more than 30 
years ago, there has been more than 25 million deaths globally and more than 60 
million people infected. There are currently 36.9 million people living with human 
immunodeficiency virus (HIV-1) globally with an estimated 2 million new infections and 
1.2 million deaths in 2014 as a result of AIDS (Unaids 2015). Sub-Saharan Africa 
(SSA) has been burdened with the highest rate of people living with HIV-1 for as long 
as the past 25 years. In 2014, there were an estimated 25.8 million people living with 
HIV-1 in SSA alone, accounting for as much as 70% of the global population living 
with HIV-1 [(Unaids 2015); Figure 1.1]. There were an estimated 1.4 million new HIV-
1 infections and 790 000 AIDS-related deaths in SSA.  There are 10.7 million people 
in SSA who have access to antiretroviral therapy (ART) with men comprising 36% and 
women 47% (Unaids 2015). Men in SSA accounts for an estimated 7.3 million people 
living with HIV-1 above the age of 15 and an estimated 1.9 million of these people are 
young adults between the ages of 15-24 (Unaids 2015). In South Africa, there are 6.4 
million people that are living with HIV-1. Young male adolescents between the ages 
of 15-24 account for 28.4% (720 000) of individuals living with HIV-1 and only 14.3% 













































































































1.2 HIV-1 staging, acquisition and transmission rates  
HIV-1 infection can be defined by three stages, the acute phase, the asymptomatic 
chronic phase and the progression to AIDS (reviewed by Coffin & Swanstrom 2013). 
Upon entry of the virus and infection of the first cell up until the virus is detectable in 
blood is termed the eclipse phase and can last between 7-21 days (Lindback et al. 
2000). The eclipse phase is clinically silent and virus can be disseminated in CD4+ T 
cells present in mucosa, submucosa, draining lymphatics and to a lesser degree, the 
gut associated lymphoid tissue (GALT) and systemic lymphatic tissues (Haase 2010). 
In 2003, Fiebig and colleagues devised a laboratory staging system whereby they 
could identify acute and early infection (Fiebig et al. 2003).  Fiebig staging can be 
categorised into stages I-IV extending from 10-30 days with each the specific stages 
lasting an average of 3-5 days, stage V lasting approximately 69.5 days and stage VI 
can be divided into recent versus early chronic infection (Fiebig et al. 2003). Figure 
1.2 summarises the Fiebig stages and assays used in the ordered appearance in 
plasma of HIV-1 viral RNA (Fiebig stage I), viral p24 antigen (Fiebig stage II) and virus-
specific antibodies (Fiebig stage III) which are detectable by recombinant protein-
based enzyme-linked immunosorbant assay and then detected by using Western 
immunoblotting (Fiebig stage IV), diagnostic banding pattern but omitted p31 reactivity 
(Fiebig stage V) and lastly diagnostic banding pattern inclusive of p31 reactivity (Fiebig 
stage VI) (Fiebig et al. 2003; reviewed by Shaw & Hunter 2012). During the chronic 
phase of infection also defined as “clinical latency,” there is a constant increase in the 
viremia level by 1-100 000 copies/ml and gradual decrease in CD4+ T cell levels. 
Patients are not always aware that they are infected with the virus at this stage. The 
level of HIV-1-RNA decreases to less than 1% of the original viral load and remains 
relatively constant, this is known as the viral set point (reviewed by Fanales-Belasio et 
al. 2010). The last phase, AIDS, is characteristic of a decrease in the number of 
peripheral blood CD4+ T cells to ± 200 cells/µl. This is due to the deterioration of the 
immune system. The body unable to maintain immune control and as a result, 
opportunistic infections begin to appear (reviewed by Coffin & Swanstrom 2013). 
There is an increase in viral load and if left untreated, the combined effects of the 
opportunistic infection and a compromised immune system will ultimately lead to the 






Figure 1.2: Fiebig stages (Taken from Shaw and Hunter., 2012). 
 
Heterosexual intercourse may apply to both penile-vaginal and penile-anal 
intercourse. A number of trials, such as HPTN052, PARTNER and VOICE, have 
reported women engaging in penile-anal sex. Furthermore, women may be at an 
increased risk of contracting HIV-1 due to both penile-vaginal and penile-anal 
intercourse (Ramjee & Daniels 2013). There are as many as 90% of men in Africa that 
have acquired the virus through heterosexual intercourse (Donoval et al. 2006). HIV-
1 transmission mainly occurs due to the exposure to virus at mucosal surfaces. It has 
been estimated that the transmission of HIV-1 during heterosexual encounters is more 
efficient from male-to-female than it is from female-to-male (Nicolosi et al. 1994; 
Carpenter et al. 1999). Powers et al., had suggested that this is not the case and that 
during a single sex act, there is no difference in the transmission of HIV-1 from male-
to-female or from female-to-male. Viral load plays a major role in determining the 
transmission risk of HIV-1 from one individual to another (Shaw & Hunter 2012).  Patel 
et al., has estimated that the risk of HIV-1 transmission through heterosexual 
intercourse in developed counties to be ~0.0008% for receptive and ~0.0004% for 




males who had sex with males (MSM) was 5 times more than receptive penile-vaginal 
intercourse, with it estimated at ~0.005% through unprotected receptive anal 
intercourse. Patel et al., has also estimated that the risk of HIV-1 transmission is 
~0.001% per coital act. In contrast to the developed countries, a meta analyses in 
Eastern and Southern Africa involving a total of 14 sites, it was estimated that men 
and women are twice as likely to acquire HIV-1 through heterosexual intercourse, with 
0.0010 and 0.0009 per coital act for men and women respectively (Hughes et al. 2012). 
These estimates of HIV-1 transmission do not explain the magnitude of the HIV-1 
burden experienced by Sub-Saharan Africa. There may be many factors that influence 
the acquisition of HIV-1 in males. A systematic review by Patel et al., and a meta-
analysis by Powers et al., suggested that factors such as a high viral load, genital ulcer 
disease, sexually transmitted infection (STIs), additional sexual partners, age, condom 
usage and whether or not the person is circumcised as well as the stage of disease 
play a role in HIV-1 acquisition.  
1.2.1 HIV-1 Transmission and Acquisition 
HIV-1 results from exposure to the virus at mucosal and percutaneous inoculation and 
can be transferred from one individual to another during sexual intercourse (Shaw & 
Hunter 2012). HIV-1 may be acquired by various means such as mother-to-child 
(MTC) transmission, heterosexual intercourse, MSM, sharing of needles by 
intravenous drug users (IDU) (WHO et al. 2014) and via abrasions in the skin. 
1.3 The skin as a barrier to HIV-1 
The skin consists of a highly specialized epithelium that is involved in prevention of 
water loss, toxin exclusion, resistance to mechanical stress and plays a role in immune 
responses. The skin is the first physical barrier of protection from invading organisms 
(reviewed by Simpson et al. 2011). Although people may not be infected through the 
skin, open cuts or wounds in the skin may make them susceptible to HIV-1 infection 
upon exposure to the virus. In an experiment by Kawamura et al. 2008, where they 
used abraded skin in explant models by using a wire brush, they showed that DCs 
were involved in virus dissemination (Kawamura et al. 2008). Keratinocytes are able 
to establish a barrier between the host and the environment by forming an adhesive 
network that has been organised into multiple layers. The skin has four main layers, 
namely the stratum basale, stratum spinosum, stratum granulosum and the stratum 




able to replace cells that are shed from the body surface and the basale cells in the 
stratum basale are fixed to the matrix and proliferate. A small portion of their daughter 
cells are then able to enter the stratum spinosum where they exit the cell cycle and 
are able to grow and establish robust intercellular connections. The cells in the stratum 
granulosum flatten and are able to assemble an impermeable water cornified envelope 
that underlies the plasma membrane. Lastly, the keratinocytes in the stratum corneum 
are completely squamous and tightly crosslinked together to form the completed 
cutaneous barrier (reviewed by Simpson et al. 2011). There are many types of cells 
that are present in the skin and these can be divided to cells that are found in the 
epidermis and dermis of the skin. The epidermis is the outer most skin layer made up 
of stratified squamous epithelium and is separated from the dermis by a thin basement 
membrane zone (Strid et al. 2009). The dermis is the inner skin layer and consists of 
a collagen meshwork, dermal fibroblasts and a high concentration of immune cells 
(Strid et al. 2009). The cells present in the epidermis include keratinocytes which are 
involved in the replacement of cells shed from the body surface, langerhans cells 
(LCs), involved in antigen presentation and T cells involved in creation of immune 
response and clearance of pathogens while the dermis contains dendritic cells 
involved in antigen presentation and induction of T cell responses, macrophages 
involved in phagocytosis of foreign substances and T cells as mentioned above 
involved in the creation of an immune response and clearance of pathogens (reviewed 
by Summerfield et al. 2015). The skin structure is similar to foreskin structure and have 




























































































































































1.4 HIV-1 at mucosal surfaces 
The mucosal layer is less robust and consists of the epithelium and lamina propria 
(eds Bellanti et al., 2012) compared to the 4 layers found in skin. The epithelial cells 
lining the mucosa play a role in innate immunity and provide a physical barrier 
(McGhee & Fujihashi 2012). The mucosal surfaces cover a total area of 400m2 and 
are therefore the primary site of antigen entry (reviewed by Borges et al. 2010; Nagler-
Anderson 2001). It is therefore not surprising that 90% of HIV-1 infections worldwide 
occur via mucosal surfaces (Kresina & Mathieson 1999). HIV-1 transmission occurs 
at the female and male genital tract, the intestinal tract, gut and draining lymph node 
(LN) (reviewed by Cohen et al. 2011; reviewed by Shaw & Hunter 2012; Deeks et al. 
2013). The GALT has many of the lymphoid cells and CD4+ T cells are rapidly 
depleted during primary infection with HIV-1 (reviewed by Swanstrom & Coffin 2012). 
Majority of the CD4+ T cells reside within the gastrointestinal tract (GIT), LNs, and 
other lymphatic tissues compared to peripheral blood (Mowat & Viney 1997), 
furthermore the GIT can be extremely permissive to HIV-1 infection and replication. 
The gut mucosa contains a high concentration of CCR5 expressing CD4+ T cells 
compared to the LN (Brenchley et al. 2004). During acute HIV-1 infection, there is 
indirect epithelial injury as well as a rapid loss of CD4+ T cells in the GIT (Brenchley 
et al. 2004; Sankaran et al. 2008). The loss of mucosal integrity observed results in 
the sustained exposure within the gut mucosa to proinflammatory microbial products 
leading to microbial translocation (Mehandru et al. 2004) in turn leading to HIV-1-
mediated CD4+ T cell depletion (Brenchley et al. 2004). Furthermore, the inflammatory 
response and tissue reconstruction during innate and adaptive immune responses 
prompted by HIV-1 replication leads to the destruction of the LN contributing to the 
depletion of CD4+ T cells (Schacker et al. 2002). Therefore, during HIV-1 infection, 
the LN, which is an organ of antigen presentation and homeostasis, becomes an organ 
of inflammation and fibrosis (Brenchley et al. 2004).  
HIV-1 is able to gain entry into the body during sexual intercourse by crossing the 
epithelial barriers that covers the mucosal surfaces of both male and female genital 
tracts as well as anal/rectal epithelia (Figure 1.4B), once HIV-1 crosses the epithelial 
barrier, it is able to establish a founder population of infected cells within hours of 
infection (Tebit et al. 2012). A review by Haase using a simian immunodeficiency virus 




the rhesus macaques with high doses of SIV at the mucosal surface, the virus is able 
to cross the mucosal epithelial barrier within hours of infection and is able to establish 
a founder population of infected cells within lymphoid tissue as seen in humans (Haase 
et al. 1996). During the first week of infection, the infected cells undergo local 
expansion and are able to generate adequate virus and infected cells in order to 
disseminate and establish systemic infection in secondary lymphoid organs (Haase 
2010). This results in the lytic destruction of susceptible CD4+CCR5+ host cells 
(reviewed by Veazey et al. 2001). In the second week of infection, the replication 
erupts in the lymphatic tissue where the virus is able to access susceptible target cells 
and the viral levels in blood and tissue peak (Figure 1.4A; Haase 2010). The first CD8 
T cell response appears before the peak of viremia and as the T cell response evolves, 
the plasma viral load falls to stable levels by four weeks after exposure, also seen in 
humans (Haase 2010; M. S. Cohen et al. 2011). The most characteristic event in the 
acute phase is the decrease in the level of peripheral blood CD4+ T cells (Fauci et al. 
1996; Clark et al. 1991). As the year’s progress, the number of CD8+ T cells are 
depleted and opportunistic infection settles in and this induces additional mucosal 
damage. The opportunistic infection may be able to prime naïve CD4+ T cells which 
results in the increase of CD4+ T cell activation and expression of CCR5 and this 
forms viral target cells (Veazey et al. 2001). The sustained increase in viral target cells 
may explain the lymphoid depletion and increase in viral load over the years leading 














































































































































































































1.4.1 Anatomy of the male genital tract 
1.4.1.1 The penis, testes and other organs  
The male penis can be measured in a flaccid and an erect state. The flaccid length of 
an adult human penis is usually 5-6cm shorter than the erect adult penis which is an 
average of 14cm in length and 12.3cm in circumference (Wylie & Eardley 2007) which 
infers that the total surface area of an erect penis averages ~200cm2 (Anderson et al. 
2011). The male genital tract (MGT) consists of the testes, the accessory glands, the 
excurrent duct system and the penis (Cao & Hendrix 2008). The excurrent duct system 
is composed of the rete testes, efferent ducts, epididymis and vas deferens while the 
accessory glands are composed of the seminal vesicles, prostate and bulbourethral 
glands (Cao & Hendrix 2008). There are two types of epithelia in the MGT, namely the 
simple and stratified epithelia. The penile urethra that consists of keratinized stratified 
squamous epithelium transitions into non-keratinized stratified squamous epithelium 
in the fossa navicularis (Figure 1.3A; reviewed by Nguyen et al. 2014). The testes is 
an immune privileged site and has two distinct regions, the interstitial spaces between 
the tubules and the seminiferous tubules. The testis is responsible for the generation 
of sperm and production of testosterone. Leydig cells comprise majority of the cell 
population that is present within the interstitial space and is responsible for the 
synthesis of testosterone (reviewed by Nguyen et al. 2014).  
1.4.1.2 The foreskin 
The male has a sheath or covering over the penis known as the foreskin or prepuce. 
This foreskin consists of a double-sided layer of stratified squamous epithelium. The 
foreskin is a continuation of skin from the pubic mound, up the shaft of the penis and 
covers the glans penis and urethral meatus (WHO & UNAIDS 2007). The frenulum, 
which is a highly vascularised tissue, attaches the glans to the foreskin. The frenulum 
also forms the interface between the inner and outer foreskin (WHO & UNAIDS 2007). 
The outer foreskin is similar to the skin on the shaft of the penis while the inner foreskin 
has a similar composition to a mucous membrane. The foreskin epidermis is 
comprised of the stratum corneum, stratum granulosum, stratum spinosum and 
stratum basale. Upon erection, the inner surface of the foreskin is exposed and is 
thought to be more susceptible to viral entry (Hussain & Lehner 1995). The foreskin 
has been studied quite extensively as this was believed to provide protection for the 




Jones 2007) glans of the penis but is now believed to be a key area in the acquisition 
of HIV-1 in males. Kigozi et al., had observed that the size of foreskin had a significant 
correlation with the HIV-1 incidence rates. It was thought that the portal of entry for 
HIV-1 could be the glans, sub-prepuce and/or the urethra (Figure 1.5; Morris & Wamai 
2012). 
1.4.1.3 HIV-1 crossing the barrier 
The foreskin is lined by stratified squamous epithelium and the external surface has 
been suggested to be more keratinised than the internal surface (McCoombe & Short 
2006; Patterson et al. 2002). The inner foreskin surface and glans are wet mucosal 
epithelia and may be more susceptible to infection (Anderson, J. a. Politch, et al. 
2011). The moist mucosa of the penis has been associated with HIV-1 acquisition in 
the MGT (O’Farrell et al. 2006). The foreskin of the penis folds back over the glans 
upon erection thereby exposing the inner foreskin mucosal epithelium to the external 
environment and an opportunity for HIV-1 entry (Figure 1.5). This exposes it to 
physical trauma and genital secretions of the female during heterosexual intercourse. 
The HIV-1 virions and infected cells of the infected partner may become trapped under 
the foreskin therefore increasing the risk of HIV-1 acquisition (Anderson, J. a. Politch, 
et al. 2011).  
The outer foreskin has been suggested to provide a greater protective barrier to HIV-
1 transmission due to the skin keratinisation. The urethra is more likely to become 
infected as it is lined with stratified, non-keratinised columnar epithelial cells (Hladik & 
McElrath 2008). The foreskin mucosa is believed to be rich in potential HIV-1 target 
cells such as LCs and CD4+ T cells in the squamous lining as well as T cells, 
macrophages and dendritic cells (DCs) in the underlying stroma (Hussain & Lehner 
1995; McCoombe & Short 2006; Patterson et al. 2002; Donoval et al. 2006). These 
cells provide immune protection by killing infected cells. However, upon entry, it is 
possible that viral escape from HIV-1 specific T immunity in the foreskin can occur 






























































































































































1.5 Target cells for HIV-1 within foreskin tissue 
1.5.1 Langerhans Cells 
Similar to the skin, the foreskin has an epidermis and a dermis with various types of 
cells present. The mucosal surface of the inner foreskin is rich in LCs (Szabo & Short 
2000). LCs are antigen presenting cells that sense foreign antigens in the environment 
with the aid of their dendrites (Merad et al. 2008), are present in the epidermis of the 
foreskin (Merad et al. 2013) and are thought to be the first immune cells to encounter 
HIV-1 (Patterson et al. 2002; Kawamura et al. 2005; de Witte et al. 2007). LCs are 
also part of the dendritic cell lineage and express the C-type lectin langerin (Patterson 
et al. 2002). Langerin is responsible for the generation of birbeck granules believed to 
be involved in the internalisation and degradation of viral particles (Romani et al. 2010; 
de Witte, Nabatov, Pion, et al. 2007). Upon capture of foreign antigens, the LCs 
migrate to the lymph node and signal to T cells in order to elicit an appropriate immune 
response, therefore LCs are important in the first immunological barrier against 
invading pathogens (Merad et al. 2008). LCs have the ability to bind to the HIV-1 
envelope glycoprotein subunit gp120 using their unique C-type lectin, langerin (de 
Witte, Nabatov, Pion, et al. 2007). In the past, LCs have been shown to transmit the 
virus to T cells upon infection (Blauvelt et al. 2000; Kawamura et al. 2001), but recent 
data shows that LCs have been able to provide protection against HIV-1 as well as the 
prevention of HIV-1 dissemination in the host (de Witte, Nabatov, Pion, et al. 2007). 
However, this is only possible at low viral concentrations (≤10 000 copies/ml), while at 
high viral concentrations (≥100 000 copies/ml) (de Witte, Nabatov, Pion, et al. 2007), 
the protective effect of langerin is inhibited allowing for the transfer of the internalized 
virus to T cells (Hladik & McElrath 2008). The role of langerin may be important in the 
fight against HIV-1. Several studies have found that LCs were detected at higher 
densities in the epithelium of the foreskin (Donoval et al. 2006) and many have 
observed that there was a greater density of LCs in the inner compared to the outer 
foreskin (Liu et al. 2014). LCs express the primary HIV-1 receptor as well as the co-
receptor CCR5, this makes LCs an ideal target for HIV-1 infection and transfer to CD4+ 
T cells (Kawamura et al. 2001). A study by Ganor et al., using an ex vivo foreskin 
explant model to determine the early events of HIV-1 exposure in the foreskin revealed 
the abundance of LCs in the inner foreskin. This showed that HIV-1 entry through the 




Kawamura et al. 2008). An in vitro model by Ganor et al., showed that infection was 
more efficient in HIV-1 infected cells compared to the cell-free virus. Upon high viral 
loads (200µl of HIV-1 infected PBMCs or cell free virus) in the foreskin, the LCs were 
infected and the formation of LC-T cell conjugates were observed in the inner foreskin 
compared to the outer foreskin (Figure 1.6; Ganor et al. 2010). In the inner foreskin, 
HIV-1 infected cells form viral synapses and results in HIV-1 particle budding [1]. At 
low viral concentrations (100µl of HIV-1 infected PBMCs or cell free virus), LCs are 
induced within the epidermis and LCs internalise HIV-1 and degrade it [2]. In a high 
viral concentration, the cells infected with HIV-1 [3] attract LCs to the mucosal surface 
where they capture HIV-1 [4] and migrate back to the epidermal-dermal interface. LCs 
are able to form LC-T cell conjugates allowing for HIV-1 transfer to T cells [5]. The 
conjugates are then able to disseminate the infection [6] (Figure 1.6; Left). In the outer 
foreskin, HIV-1 infected cells are able to form viral synapses with apical foreskin 
surface [7]. HIV-1 virions become trapped within thick keratin layer at mucosal surface 
and thereby preventing HIV-1 dissemination [8,9] (Figure 1.6; Right). This could be 
representative of events that take place in vivo, with LCs playing a role in HIV-1 





Figure 1.6: Initial HIV-1 transmission events in the inner and outer foreskin 
(Taken from Ganor et al., 2010). 
 
1.5.2 CD4 T cells and co-receptors 
Lynch et al., showed that a small population of CD1a positive LCs were positive for 
CD4 expression. CD4 is a cell surface molecule which is expressed by a subtype of T 
lymphocytes and is a primary receptor for HIV-1 (Patterson et al. 2002). CD4+ T cells 
are present in the mucosal layer of the foreskin and are targets for HIV-1 infection 
(Patterson et al. 2002). Donoval et al., showed that the CD4+ T cells are found deep 
in the tissue and are therefore not likely the first cells to come into contact with HIV-1. 
DCs, LCs and CD4+ T cells are present in the foreskin (Donoval et al. 2006; Patterson 
et al. 2002; Liu et al. 2014). CD4+ cells are the main targets of HIV-1 infection, which 
is transported across epithelial barriers covering the mucosal surface of the penis 




LC-T cell conjugates at high viral concentrations and LCs transferred the virus to T 
cells (Ganor et al. 2010). However, this process has not been identified in vivo. There 
has recently been a penile SIV infection model that has shown encouraging results 
(Ma et al. 2011). Studies of vaginal mucosa has shown that the stratified squamous 
epithelium of the vagina contains LCs (Hladik & McElrath 2008; Nguyen et al. 2014). 
An ex vivo experiment showed that LCs can be infected by HIV-1 and move to the 
submucosa (Hladik et al. 2007). The submucosa contains DCs which may also be 
infected and transmit HIV-1 to CD4+ T cells (Hladik et al. 2007). Both DCs and CD4+ 
lymphocytes are able to be infected via receptor dependant mechanisms that allow 
the virus to spread to lymph nodes and subsequently the bloodstream and viral 
replication occurs extensively in the lymphatic tissue of infected mucosae and lymph 
node (Spira et al. 1996; Hu et al. 2000). Infected CD4+ can undergo lysis or allow for 
the establishment of latent infection, which may act as permanent reservoirs (Aleaki 
et al. 2008). It can be hypothesized that similar events that are seen with vaginal 
models may occur in the penis, but further research needs to be conducted to identify 
how HIV-1 is acquired in the male genital tract. CD4+ T cells are heterogeneous in 
their expression of the CCR5 co-receptor and the expression of CXCR4 is 
predominantly expressed on memory and naïve T cells (reviewed by Swanstrom & 
Coffin 2012). Upon HIV-1 infection, the gradual decrease in CD4+ T cell numbers 
eventually lead to AIDS (Mehandru et al. 2004). There are a greater proportion of the 
CD4+ T-lymphocyte population in the gastrointestinal mucosa and other secondary 
lymphoid organs compared to those found in peripheral blood (Brenchley et al. 2004). 
Prodger et al., have shown that there are four times the amount of CD4+ T cells in the 
foreskin mucosa compared to that of blood. There have been 3 groups that have found 
different results with the number of CD4+ T cells found in the foreskin, Hussain and 
Lehner found no differences in the number of CD4+ T cells between the inner 
compared to the outer foreskin, McCoombe and Short found more CD4+ T cells in the 
outer compared to the inner foreskin and Patterson et al., found more CD4+ T cells in 
the inner compared to the outer foreskin.  The differences in results from these three 
groups may be due to confounder effects in the individuals such as the presence of 
an infection and the different methodologies used by each group. These may include 




1.5.3 Dendritic cells and Macrophages 
CD4 expression has also been shown on DCs and is involved in the inhibition of DC-
mediated HIV-1 transmission to CD4+ T cells (Wang et al. 2007). DCs are able to 
express the C-type lectin Dendritic cell specific intercellular adhesion molecule 3- 
grabbing non-integrin (DC-SIGN), and this functions as an adhesion molecule (van 
Kooyk & Geijtenbeek 2003). DC-SIGN binds Intercellular adhesion molecule (ICAM)-
3 on T cells with high affinity thereby allowing for a stable DC-T cell immunological 
synapse (Van Gisbergen et al. 2005). DC-SIGN is also able to bind virion-associated 
HIV-1 Env (reviewed by Coleman et al. 2013) but overexpression of DC-SIGN may 
promote HIV-1 entry and infection (Lee et al. 2001). It is postulated by several studies 
that DC-SIGN on DCs bind HIV-1 virions and may allow for transfer of HIV-1 from DCs 
to CD4+ T cells  due to the binding of HIV-1 envelope glycoprotein, gp120 to DC-SIGN 
(Geijtenbeek et al. 2000). DC-SIGN similarly to langerin plays a role in the 
internalisation of HIV-1 perhaps protecting the virus from degradation prior to viral 
synapse formation and CD4+ T-cell engagement (reviewed by Coleman et al. 2013). 
Macrophages are found in the lamina propria which is adjacent to the mucosal 
epithelium, they may come into contact with HIV-1 due to genital ulcerations and 
abrasions in the mucosal epithelium (Zaitseva et al. 1997).  The exchange of 
information between the macrophages and CD4+ T cells plays an important role in the 
transmission of HIV-1 from macrophages to CD4+ T cells (Crowe et al. 1992; Groot et 
al. 2008). Macrophages infected with HIV-1 are able to survive for long periods as a 
viral reservoir (Gorry et al. 2014) and comprise up to 10% of infected cells (Zhang et 
al. 1999). HIV-1 tropism for macrophages is determined by the CD4 receptor as well 
as both CCR5 and CXCR4 co-receptor expression (Duncan & Sattentau 2011). Baxter 
et al., conducted a series of experiments and found that primary monocyte-derived 
macrophages (MDMs) are able to selectively capture HIV-1 infected CD4+ T cells 
leading to the infection of macrophages and efficient transfer of HIV-1 from cell-to-cell. 
They co-cultured MDMs with CD4+ T cells expressing either CCR5 or CXCR4 or 
uninfected CD4+ T cells and showed that cell death of HIV-1 infection of CD4+ T cells 
increased their uptake by macrophages showing the efficient capture of the HIV-1 
infected CD4+ T cells independent of co-receptor specificity of HIV-1. This uptake of 
HIV-1 infected CD4+ T cells could potentially lead to the infection of macrophages 
leading to the diffusion of HIV-1 in vivo (Baxter et al. 2014). Although other receptors 




HIV-1 is only able to cause infection of cells that it is able to enter (Patterson et al. 
2002).  
 
1.6 Factors enhancing HIV-1 infection 
HIV-1 disease progression is characterised by the damage and loss of CD4+ T cells 
as well as an impaired function of a range of immune cells. The hyper-activation of the 
immune system and activation induced cell death has been shown as a major 
mechanism driving HIV-1 disease progression (Hunt 2007; Douek et al. 2009). There 
may be other factors that contribute to the elevation in HIV-1 infectivity rates such as 
STIs and other co-infections (Stillwaggon & Sawers 2015).  
1.6.1 Immune activation and inflammation during HIV-1 infection 
Inflammation can be defined as the complex biological response of vascular tissues 
to injury or harmful stimuli such as those inflected by pathogens, damaged cells and 
irritants (eds Bellanti et al., 2012) and immune activation is the activation of cellular 
components of the immune system (Hsu & Sereti 2014). 
Mucosal inflammation enhances HIV-1 transmission rates from an HIV-1-infected to 
an uninfected individual (Kaul et al. 2015). Inflammation leads to plasma and immune 
cell extravasation to the site of injury resulting in the clearance of the pathogen and 
promotion of tissue healing. The early mediators of inflammation are produced 
following innate immune activation and involves pro-inflammatory cytokines and 
chemokines released by several cell types such as epithelial cells, tissue-resident DCs 
and macrophages as well as innate lymphoid cells amongst others (Bamais et al. 
2014). The prototypic pro-inflammatory cytokines include interleukin (IL) -1a and tumor 
necrosis factor alpha (TNF-α), to a lesser extent, IL-8, IL-6 and interferon gamma (IFN-
γ) (Dinarello 2000). The increased expression of these cytokines at the mucosal 
surface enhances HIV-1 transmission (Kaul et al. 2015). TNF-α is involved in the direct 
reduction of epithelial barrier integrity by the disruption of tight junction proteins, 
namely ZO-1 and occludin thereby enhancing HIV-1 viral entry to the submucosal 
targets (Nazli et al. 2010). The chemoattractant properties of the cytokines and 
chemokines leads to the recruitment of activated CD4+ T cells to the mucosa resulting 
in increased target cells for HIV-1 (Kaul et al. 2015). The higher levels of pro-




correlated with the increased HIV-1 RNA viral load seen in semen (Olivier et al. 2014) 
and vaginal secretions (Gumbi et al. 2008).  
Chronic inflammation has been shown to play a central role in the pathogenesis of 
HIV-1 infection without treatment. Acute HIV-1 infection has been associated with the 
rapid and intense release of cytokines such as IFN-α, IFN-γ, inducible protein 10 (IP-
10), TNF, IL-10, IL-6 and IL-15 (Stacey et al. 2009). During acute HIV-1 infection, the 
frequency of activated T cells is increased drastically in peripheral blood and almost 
50% of which are CD8+ T subsets. The potential sources of inflammation may involve 
HIV-1 replication directly contributing to T cell activation (Papagno et al. 2004), 
contribution of other opportunistic infections such as herpes viruses enhancing high 
level T cell activation (Smith et al. 2013; Wittkop et al. 2013), HIV-1-mediated 
breakdown in the gut mucosa and chronic exposure to gut microbial products such as 
lipopolysaccharide (LPS) (Brenchley et al. 2006) and the impaired function of 
immunoregulatory factors that may also contribute to the persistence of inflammation 
in lymphoid tissues (Deeks et al. 2013). A large percentage of CD4+ T cells are also 
capable of producing cytokines in situ, indicating that they are terminally differentiated 
effector cells (Mowat & Viney 1997). Importantly, the cytokines and chemokines that 
are secreted by epithelial, stromal and immune cells are able to recruit neutrophil, 
monocytes, macrophages, DCs, T cells and natural killer (NK) cells (reviewed by 
Rancez et al. 2012). CD4+ T cells are a subset of helper T lymphocytes (Th) and are 
the main target for HIV-1. HIV-1 is also able to infect macrophages and DCs that 
express the CD4 molecule on its surface. CD4+ T cell levels are decreased in three 
ways, the direct viral killing of the cells, increase of apoptosis in infected cells and 
killing of the infected cells by cytotoxic T lymphocytes (CTL) (Huang et al. 2012). The 
Th cells do not play any role in the cytotoxic or phagocytic activity directed towards 
pathogens and do not kill any infected cells or pathogens. Their role involves the 
activation and proliferation of CTL and B cells as well as the determination of B cell 
antibody class switching (Huang et al. 2012).  
The gut mucosa contains CD4+CCR5+ T cells at a high concentration (Deeks et al. 
2013). During acute HIV-1 infection, the virus is disseminated rapidly throughout the 
GALT which leads to the direct loss of CD4+ T cells and indirectly to epithelial injury 
(Sankaran et al. 2008). Up to 60% of the T cells found within mucosal surfaces  




1.6.2 Inflammatory milieu 
The increase in HIV-1 viral load corresponds with the surge of inflammatory cytokines 
led by IFN-α and IL-15 (Stacey et al. 2009). DCs are the earliest cells to produce 
cytokines and later during the infective process, cells such as monocytes, 
macrophages, NK cells and T cells are able to produce cytokines (Borrow & Bhardwaj 
2008). NK cells play an important role in the innate immune system and in anti-viral 
and anti-tumour responses. Upon activation, NK cells function primarily by killing virus-
infected or tumour cells or they produce large amounts of cytokines, IFN-γ in particular, 
to activate macrophages to kill intracellular bacteria (Wira et al. 2005). Both DCs and 
macrophages are sentinels of the mucosal immune system and are constantly 
surveying and processing antigens from the external environment in turn providing 
important information and signals to the host immune system (reviewed by Nguyen et 
al. 2014). T cells are able to proliferate in response to cytokines in T-cell receptor 
(TCR) independent manner (Geginat et al. 2003; reviewed by Seder et al. 2008). IL-
2, TNF-α and IFN-γ are the main effector cytokines that are involved in T-cell 
differentiation and formation of T-cell responses (Mahnke et al. 2013). IL-2 production 
determines whether T cells become effector or memory cells due to their impact on 
proliferation, differentiation and survival of antigen-specific T cells (Kalia et al. 2010). 
Thus, cytokine production may enhance antiviral immune responses in acute HIV-1 
infection but the prolonged cytokine storm may also contribute to the harmful immune 
activation and loss of CD4+ T cells (reviewed by Cohen et al. 2011). Other factors 
contributing to the inflammatory milieu are STIs. STIs are able to increase an already 
inflamed surface. Symptomatic STIs, such as herpes simplex virus (HSV)-2, have 
been shown to be associated with increased inflammation and immune activation 
(Johnson et al. 2009). Asymptomatic STIs, such as Chlamydia Trachomatis (CT), have 
also been associated with the increase in inflammation in the genital region (Kokab et 
al. 2010; Buckner et al. 2016).  
1.6.3 Bystander activation 
Inflammation due to the influx of cells to the site of the infection caused by an invading 
pathogen/virus may induce the activation of surrounding immune cells, this is known 
as bystander activation (Moir et al. 2011). During HIV-1 infection, CD4+ T cells are 
depleted from lymphoid systems, by the virus itself and as a consequence of bystander 




cause changes to the inflammatory milieu, contributing to bystander activation, with 
the introduction of cytokines such as IL-2, IL-6, IL-7 and IL-12 capable of increasing 
the susceptibility of surrounding resting cells to HIV-1 infection (Unutmaz et al. 1999). 
Lemos et al., found differences in the inflammatory milieu in the inner versus outer 
foreskin and the presence of this inflammatory milieu was supported by the increased 
secretion of granulocyte macrophage colony stimulating factor (GM-CSF), IP-10 and 
regulated on activation, normal T expressed and secreted (RANTES) which increased 
the density of CCR5+ and CD4+CCR5+ cells. Prodger et al., found that HIV-1 
exposed-resistant men had lower levels of Th17 cells and TNF-α producing CD4 and 
CD8 T cells compared to unexposed controls. The reduction of IL-17 and TNF-α may 
reduce bystander activation of other CD4+ T cell and dendritic cell populations (Jong 
et al. 2008) and indirectly reduce the number of HIV-1-susceptible cells (Prodger et al. 
2014). One could therefore hypothesize based on findings by Lemos et al and Prodger 
et al that changes in inflammatory milieu in the foreskin can lead to bystander 
activation of T cells and increase in HIV-1-susceptibility. 
1.6.4 The impact of STIs on bystander activation and HIV-1 
Symptomatic STIs such as HSV-2 along with other co-infections facilitate HIV-1 
transmission and acquisition (Gray et al. 2001; Korenromp et al. 2005; Reynolds et al. 
2003; Stillwaggon & Sawers 2015). STIs and other genital infections have also been 
linked to the increase of HIV-1 genital shedding (Corbett et al. 2002; Cohen & Pilcher 
2005; Anderson et al. 2010). These infections include cytomegalovirus (CMV), 
gonorrhoea, chancroid, syphilis, genital herpes, bacterial vaginosis (BV) as well as 
candidiasis (reviewed by Kaul et al. 2008). The biological findings support the 
mechanism that STIs increase HIV-1 acquisition and transmission by the direct 
mucosal disruption, recruitment of HIV-1 target cells to the genital tract and by the 
increase in HIV-1 plasma viral load and genital secretions (reviewed by (Ward & Rönn 
2010). Studies that have been conducted on foreskins from men that had an 
asymptomatic STI (HSV-2) or previous history of a STI have shown that the infections 
were associated with inflammation and an increase in the number of HIV-1 target cells 
(Patterson et al. 2002; Johnson et al. 2009).  
STI prevalence rates are high in South Africa and the prevalence of some STIs 
exceeds those estimated in various African households (Johnson et al. 2005). There 




Genitalium (MG), Neisseria Gonorrhoeae (NG) and CT which are bacterial STIs and 
Trichomonas Vaginalis (TV) which is a protozoan STI.  
STIs enable HIV-1 transmission by increasing both the infectiousness (Korenromp et 
al. 2005; Gray et al. 2001) and susceptibility (Reynolds et al. 2003; Wawer et al. 2005; 
Freeman et al. 2006). A large influence is the presence of genital ulcer disease (Wawer 
et al. 2005; Gray et al. 2001) such as NG (Macdonald et al. 2008), chanchroid, 
infectious syphilis (Buchacz et al. 2004), TV (McClelland et al. 2007) and HSV-2 which 
increases the susceptibility to HIV-1 (Cameron et al. 1989; Anderson et al. 2010). 
Biological findings have shown that STIs such as HSV-2, NG and HPV increases 
susceptibility (Cohen et al. 1997; Freeman et al. 2006; Auvert et al. 2009), and HSV-
2 has been shown to increase HIV-1 target cell recruitment to the genital tract 
(reviewed by Johnson & Lewis 2008). 
 
1.7 Medical Male Circumcision as an HIV-1 prevention method 
There have been three randomised controlled trial in Africa that have shown male 
circumcision provides up to 60% protection against the acquisition of HIV-1 (Gray et 
al. 2007; Bailey et al. 2007; Auvert et al. 2005), furthermore an uncircumcised man 
has a 1.8 to 8.2-fold increased chance of acquiring HIV-1 compared to a circumcised 
man (Donoval et al. 2006). The foreskin also has a higher density of HIV-1 target cells 
and may be susceptible to epithelial disruptions during sexual intercourse, providing 
additional portals of entry for HIV-1 (Weiss & Quigley. 2000; Weiss et al. 2006). The 
removal of the foreskin would reduce the number of target cells for HIV-1 (McCoombe 
& Short 2006; Fischetti et al. 2009). Circumcision has also been shown to reduce the 
chances of STI acquisition (Auvert et al. 2001; Weiss et al. 2001; Bwayo et al. 1994; 
Cook et al. 1994; Baldwin et al. 2003) and will be discussed further below.  
1.7.1 Male Circumcision prevalence 
Medical male circumcision (MMC) is the complete surgical removal of the foreskin that 
covers the glans of the penis under local anaesthesia (Figure 1.7). There are currently 
on 30% of men worldwide that circumcise due to religious, cultural or medical reasons 
(WHO & Unaids 2007). WHO and UNAIDS have set established recommendations to 
reach 80% of male circumcisions in men aged 15-49 in 14 countries in East and 




rates, by 2016 (reviewed by Tobian et al. 2014). The total number of MMCs aimed to 
achieve is 20.8 million and between 2011 and 2014 there have been a total of 9.1 
million (44%) circumcisions in the 14 countries (WHO 2015; World Health 
Organization/Joint United Nations Programme on HIV-1/AIDS 2011). In SSA there has 
been a total of 5.8 million circumcisions achieved to date. South Africa has achieved 
1.8 million of the total 4.3 million target of MMCs. The continued scale up of MMCs is 
needed to help achieve the target of 80% set out by WHO and UNAIDS. A review on 
the acceptability of circumcision in SSA suggested that 65% of uncircumcised men 
are willing to undergo circumcision, 69% of women prefer partners who are 
circumcised and that 71% of men and 81% of women would consider circumcising 
their sons (Westercamp & Bailey 2007). 
1.7.2 Protection against other STIs 
Circumcision has been shown to be protective against STIs. The randomised 
circumcision trials in Uganda and Kenya was associated with the decreased frequency 
of genital ulceration (Gray et al. 2007; Mehta et al. 2012). Prior to these circumcision 
trials, other observational studies showed that male circumcision may play a role in 
the decrease of infection with high-risk HPV (Baldwin et al. 2003; Lajous et al. 2005). 
In HSV-2, MMC decreased the chance of infection by 25% and HPV by 35% (Tobian 
et al. 2010). Male circumcision was also evaluated on the risk of bacterial STI 
acquisition among men. The South African trial found that male circumcision 
decreases TV and CT (Sobngwi-Tambekou et al. 2009) but had no impact on NG 
(Auvert et al. 2009) and the Kenyan trial found no protective effect for NG, CT or TV 
but only found a protective effect for MG (Mehta et al. 2009).  
1.7.3 Immunological basis for protection 
Although male circumcision has been shown to reduce the prevalence of STIs in 
heterosexual men, the effects among MSM is not clear, while some studies have 
shown that male circumcision is associated with decreased risk of infection 
(Buchbinder et al. 2005). Prodger et al, found a higher proportion of CD4+ and CD8+ 
T cells in the foreskin compared to blood and Lemos et al, suggested that the 
combination of increased inflammation and alterations to epithelial barriers in the inner 
foreskin may contribute to STIs and HIV-1 in uncircumcised men therefore 
emphasising the need for circumcision. This was further supported by Liu et al, who 




to the outer and suggested that this provides a biological explanation for male 
circumcision in preventing HIV-1 infection. MMC may also confer protection for female 
partner. Two studies have shown that MMC reduces the risk of cervical cancer in 
females (Castellsagué et al. 2002; Drain et al. 2006) while only one study has shown 
no protective effect (Brinton et al. 1989). 
1.7.4 Other HIV-1 prevention methods 
There has been much research that has been put into the development of a HIV-1 
vaccine over the years to prevent HIV-1 transmission. Although there have been many 
studies that have acquired a high efficacy of protection, none have been able to 
provide one hundred percent protection. Globally, in 2015, there were 15.8 million 
people that had access to ART with 41% of adults accessing ART in 2014 compared 
to 23% in 2010. In SSA alone, there were 10.7 million people who had access to 
antiretroviral (ARV) treatment up from fewer than 100 000 people in 2002 (Unaids 
2015). HIV-1 prevention tools such as abstinence, condom usage, monogamy, 
microbicides, ART and oral pre-exposure prophylaxis (PrEP) is needed to aid in the 
prevention of the HIV-1 transmission. HIV-1 has a vast rate of mutation, thereby 
enabling it to evade host immune responses (Korber et al. 2009). Vaccine design has 
been focused on the induction of cell-mediated immune responses that lower viral 
loads as well as eliciting neutralising antibodies capable of providing sterilising 
immunity (Kim et al. 2010; reviewed by Walker & Burton 2008). Biomedical measure 
to prevent the transmission of HIV-1 have shown a great promise. The use of ARV 
drugs in PrEP has been shown to protect against the sexual transmission of HIV for 
both men and women in four clinical trials: the CAPRISA 004 (Karim et al. 2010), iPrEx 
(Grant et al. 2010), TDF2 (Thigpen et al. 2012) and Partners in Prevention (Baeten et 
al. 2012). Only partial protection was observed in the CAPRISA 004 trial. The HPTN 
052 trial was a treatment for prevention strategy and showed that antiretroviral 
treatment was 96% efficacious in preventing transmission (Cohen et al. 2011). The 
RV144 vaccine trial however, showed a modest efficacy of 31% at 3 years (Rerks-
Ngarm et al. 2009; Pitisuttithum et al. 2013). Furthermore, a study in 2015 found that 
PrEP reduced the risk of HIV-1 infection by 86% in MSM (McCormack et al. 2016). 
The initiation of highly active anti-retroviral drug combination therapy (HAART) 
decreases the viremia in plasma and blood CD4 counts rise (reviewed by Lackner et 




in the reduction of HIV-1 replication, it is unable to completely eliminate infection. 
Therefore, the development of prevention strategies such HIV-1 vaccines, ARV-based 




















































































1.8 Aims and Objectives 
Overall aim of thesis 
The aim of this thesis was to optimise the techniques used to retrieve the 
maximum amount of viable cells from the inner and outer foreskin of fresh and 
frozen tissue and investigate the number of immune cells present in the inner 
and outer foreskin by immunofluorescence. 
Specific objective 1: 
To isolate the optimal amount of viable cells from foreskin tissue. 
Hypothesis: 
There will be a higher percentage of viable cells retrieved from fresh tissue. 
Specific Objective 2: 
To examine the levels of keratinisation in the inner and outer foreskins after 
medical male circumcision. 
Hypothesis: 
There are no differences in the keratinisation of the inner and outer foreskin. 
Specific Objective 3: 
To investigate the numbers of CD4+ T cells in the inner and outer foreskin. 
Hypothesis: 
There are no differences in CD4+ T cell density in the inner and outer foreskin 
Specific Objective 4: 
To identify the impact of asymptomatic STIs on the numbers and activation 
status of foreskin-resident CD4+ T cells. 
Hypothesis:  
Males with an asymptomatic STI have higher levels of activated immune cells 
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A. Materials and Methods 
 
2.1 Study participants and setting 
A total of one hundred and fifty participants between the ages of 14 and 24 was 
recruited. 
Cohort 1: One hundred and nine participants were recruited from Edendale 
Hospital (EDH), Pietermaritzburg, Kwa-Zulu Natal. This hospital offered district 
and regional level services to a catchment area of approximately 1 million 
people, including Medical Male Circumcision (MMC) for boys and men from the 
Edendale Valley.  
The participants were recruited from the Research Ready Cohort that attended 
the WhizzKids United, Africa Aid (WKUHA), an adolescent-friendly care clinic 
and recreation centre at the EDH. WKUHA offers HIV-1 testing, MMC, 
antiretroviral treatment, sexual risk assessment, screening for sexually 
transmitted infections as well as primary healthcare services such as support 
for orphans and vulnerable children, and career guidance. This facility and 
services represented a multi-stake partnership between WKUHA, the Kwa-Zulu 
Natal Department of Health and Edendale Hospital.  
Cohort 2: Forty one participants were recruited from the Khula Ndoda 
circumcision clinic at the Chris Hani Baragwanath (CHB) Hospital, Diepkloof, 
Gauteng. The Khula Ndoda circumcision clinic was opened by the Perinatal 
HIV-1 Research Unit (PHRU) in 2010 and engages in research, training, policy-
formulation and advocacy that concerns HIV-1-positive people and their 
children. Khula Ndoda offers free MMC to residents of Soweto and surrounding 
communities. They provide HIV-1 testing, antiretroviral treatment, sexual risk 
assessment, screening for sexually transmitted infections and other primary 






The following inclusion criteria were applied: 
1. Scheduled for elective MMC 
2. Age 14– 24 years 
3. HIV-1 seronegative tested within the past 30 days 
4. Informed consent or parental/guardian consent and participant assent if 
<18 years 
5. Reside within approximately 5km of the clinic 
The following exclusion criteria was applied: 
1. Inclusion criteria not met 
2. Unknown HIV-1 status or HIV-1 seropositive 
3. Informed consent/assent not obtained 
 
Ethics approval for the study was obtained from the University of Cape Town 
(UCT) Faculty of Health Sciences Research Ethics Committee (HREC Ref: 
566/2012). 
2.2 Sample Collection 
Three follow-up visits were scheduled for the participants at the Edendale 
Hospital and two follow-up visits at Chris Hani Baragwanath Hospital. 
Participants were evaluated in accordance with the study schema shown in 




Table 1: Participant evaluation 
      
Procedure At 
Booking 






Assent/ Consent X     





X X X X 
MMC  X    
Foreskin collection  X    
Penile swab  X X X X 
HIV-1 and STI testing  X  X X 
Hormone testing  X    
 
Samples: 
To test for a panel of STIs, first pass urine was self-collected and deposited in 
a 40ml blue-capped specimen jar (Lasec, Cat. No.: PLASEC15839R) at the 
EDH site while urethral swabs were taken at the CHB site. All urine samples 
and swabs were sent to the National Health Laboratory Service (NHLS) for 
testing. To assess changes in the bacterial microbiome, a swab was taken from 
the coronal sulcus (head ridge) and glans of the penis underneath the foreskin. 
This was placed in a labelled (S1) Primestore tube. (Primestore MTM, Longhorn 
Vaccines & Diagnostics, San Antonio, Lot no. 2684C145). A second swab was 
taken from below the head of the penis, around the shaft of the penis. This was 
placed in a labelled (S2) Primestore tube. Blood samples (6ml) were collected 
to test for testosterone levels, HIV-1, and peripheral blood mononuclear cell 
(PBMC) extraction. Blood collection was done in a purple top EDTA vacutainer 




was taken in a green top NaHep vacutainer [Greiner Bio-One (Lasec, Cat. No.: 
VGRV456028)]. The foreskin was excised by a surgical team subsequent to a 
pre-surgical examination of the foreskin and penis for any visible complications 
or any symptomatic STIs. If there were no complications, a local anaesthesia 
was applied to the sites of excision and either a Tara Klamp (EDH, KZN) or 
forceps (CHB, Gauteng) was used to facilitate the circumcision. The excised 
tissue was then placed into a 50ml (BD Falcon (Scientific Group, Cat. No.: 
352070) blue-capped tube containing 15ml of R15 (Table S2) media, 
Penicillin/Streptomycin (Gibco, Cat. No.: 15070-063) and Fungin (InvivoGen, 
Cat. No.: ant-fn-2)]. Samples were then shipped by an overnight courier on ice 
from the KZN site to the lab at UCT for processing within 24 hours and samples 
from the JHB site were transported by car from the hospital to the NHLS for 
processing within 4 hours. 
2.3 Sample processing and storage 
Upon arrival of the foreskin samples in the lab, the R15 media in the 50ml 
container was poured out. The foreskin was rinsed twice in 40ml phosphate 
buffer saline (PBS) (Table S2) to ensure that all blood was rinsed off the tissue. 
The foreskin was then placed in a petri dish (epidermis facing up) and spread 
out as flat as possible using disposable forceps (B&M Scientific, Cat. No. 
XFPB0015) to facilitate the dissection of the inner from the outer foreskin. The 
inner foreskin was separated from the outer foreskin (Figure 2.1) using a sharp 
disposable scalpel (Lasec, Cat. No. HFLS13242), cutting in a ‘see-saw’ motion. 
The inner and outer foreskin was cut into small blocks of approximately 0.8-
1cm3 for maceration and the remainder was cut into 5-7mm3 blocks for tissue 
sectioning and subsequent immunofluorescent staining. To be able to 
normalise using weight, the weight of each block was recorded before being 
placed in labelled cryovials containing 1 ml of 10% freezing media. The freezing 
media was added dropwise to the cryovials. The cryovials were then placed in 
ice-cold Mr Frosty’s (Nalgene®; C1562, Sigma-Aldrich) and stored at -80°C 
overnight. The samples were then transferred to liquid nitrogen the next day for 
long-term storage. To ensure adequate space for tissue blocks, Cryo-molds 
were created by folding strips of double-sided aluminium foil (10x10cm) around 




flattened bottoms. The molds were then filled with Optimal Cutting Temperature 
(OCT) liquid (Leica, Cat. No. 14020108926) to approximately 1cm height. A 
piece of foreskin tissue was then placed in each mold ensuring that the tissue 
was placed in the correct orientation (Figure 2.2A) and immediately placed at -
80°C overnight. The open ends of the cryo-molds were then closed the next 




Figure 2.1: Foreskin tissue sample. The red dotted line separates the Inner 
(light in colour) from the Outer (dark in colour) foreskin. 
 
 
Figure 2.2: Tissue orientation and sectioning A) Correct orientation of 
tissue in OCT. B) OCT block placed on chuck (left) in preparation for 







2.4 PBMC isolation and storage 
PBMC isolation: Upon arrival of blood samples in respective laboratories, 3ml 
of ficoll was pipetted in 12ml leucosep tubes and centrifuged at 1500 revolutions 
per minute (rpm) for 2 minutes (min). The blood tubes were inverted a few times 
before being carefully poured in 12ml leucosep tubes and centrifuged at 
1500rpm for 5 min. For testosterone and internal HIV-1 testing, approximately 
500μl of plasma layer was removed using a 1ml pipette and placed in two 
labelled cryovials and this was stored at -80°C. To isolate PBMCs, gradient 
separation using 12ml Leucosep (Greiner Bio-one; Cat. No. 89048-932) tubes 
with 3ml Ficoll (Table S2) were used. To facilitate a homogenous suspension, 
blood tubes were inverted several times and layered on leucosep dividers 
above the Ficoll. The tubes were centrifuged at 2500rpm for 15 min. A fresh 
sterile pasture pipette was used to transfer the ‘buffy’ layer of PBMCs into 15ml 
tubes and 1% wash buffer (Table S2) was used to top up the volume to 15ml. 
The tube was centrifuged at 1200rpm for 10 min to wash away all contaminating 
ficoll. The supernatant was discarded and the pellet was gently re-suspended. 
Following a second wash step, the supernatant was discarded, the pellet re-
suspended and transferred to a cryovial. Fetal Bovine Serum (FBS) (Table S2) 
was added to the pellet to make up 500μl in total. A further 500µl of freezing 
media (Table S2) was then added dropwise with intermittent gentle shaking. 
The cryovial was then placed in a Mr Frosty which was kept at 4°C and then 
transferred to -80°C overnight before being transferred to a vapour phase liquid 
nitrogen cryotank (Cryo 200, Forma Scientific) the next day.  
 
2.5 Urine samples:  
Processing and storage: To ensure that all possible bacteria were flushed out 
for STI testing, self-collected first pass urine received in the laboratories was 
aliquoted into 4 labelled cryovials of 1.5ml each and stored at -80°C. Within the 
same week of sampling, 1 tube was sent to the NHLS for STI screening.   
STI screening: STI detection was performed using the urine samples from the 
Edendale site and urethral swabs from the Johannesburg site to screen for the 




genitalium (MG), HSV-1 and HSV-2. Multiplex real time Polymerase Chain 
Reaction (PCR) was used for the detection of these STIs. Briefly, this method 
allows for the amplification of several DNA sequences simultaneously. This 
process amplifies the DNA in the samples by use of multiple primers as well as 
temperature mediated DNA polymerase in a thermal cycler. The bands 
produced are visualised using gel electrophoresis, this allows for the detection 
of a STI (Chamberlain et al. 1988). Human Papilloma Virus (HPV) was detected 
by DNA extraction from penile cells that were collected using a urethral swab. 
This was performed using a MagNa Pure Compact Nucleic Acid Isolation kit 
(Roche) and an automated MagNa Pure Compact machine (Roche). The HPV 
typing was performed by using a Roche Linear Array HPV Genotyping assay 
as per manufacturer’s instructions.  
 
2.6 Foreskin cell isolation 
2.6.1 Liberation of cells 
To liberate cells for flow cytometric analysis, pieces of inner and outer foreskin 
were cut into strips and then further sectioned to create 24 pieces of 
approximately 0.25 cm2. To enzymatically digest collagen within skin, each 
piece was placed in a 1.5ml eppendorf tube containing 0.5ml of 500U/ml -1 
Collagenase Type 1 (Life Technologies, Cat. No. 17018-029) and 200U/ml-1 
DNAse 1 (ThermoFisher Scientific, Cat. No. 89836) in RPMI 1640 media. 
Stainless steel scissors with curved edge blades were used to mechanically 
disrupt each piece of tissue in a 1.5ml eppendorf. A further 0.5ml of collagenase 
media (Table S2) was added to each eppendorf and was then placed on a 
shaker at 900rpm for 30 min at 37°C. In a separate 50ml tube, 1.5ml of FBS 
was added. After incubation, the cellular suspension was added to the tube 
containing the 1.5ml FBS. A further 0.5ml of R10 (Table S2) was added to each 
eppendorf to rinse all contents in the eppendorf tube and the contents were 
added to a 50ml tube. The resulting suspension was filtered using a 100µm 
filter to ensure that only liberated cells were collected (BD cell strainer, 100μm, 
Cat. No. BD/352060). In order to liberate the optimal amount of cells, the tube 
that contained the undigested tissue aggregate was rinsed with 5ml of R10 




for 10 min, the supernatant discarded and the cells re-suspended. To determine 
the number of viable cells, a cell count was done using the TC20 cell counter 
(BIO RAD, Model no. TC20TM Automated Cell counter). A total of 10ml of R10 
and 150U/ml-1 DNAse 1 was added to the cells and centrifuged at 1860rpm for 
10 min. The supernatant was discarded and cells re-suspended in 400µl R10 
and 200 µl was transferred to two wells in a 96-well V-bottom plate for 
subsequent flow cytometric staining (Protocol adapted from Prodger et al. 
2012). 
2.6.2 Flow Cytometry and foreskin cell staining 
Continuing from above, the plate was centrifuged at 2100rpm for 3 min. The 
supernatant was then discarded. A volume of 100µl of 1% wash buffer (Table 
S2) was added to each well, the cell pellet was re-suspended and transferred 
to one well. The plate was then centrifuged at 2100rpm for 3 min, flicked onto 
a stack of paper and blotted dry. To measure viability, a Vivid (Life technologies, 
Cat. No. L34955,) dye solution was prepared (1:40 i.e. 39µl PBS + 1µl Vivid) 
and 1µl was added to a 100µl of staining volume in each well and cell pellets 
re-suspended. The plate was incubated at room temperature (RT) for 20 min in 
the dark. Vivid binds to the free amine groups in the cytoplasm of damaged 
cells but it is unable to bind to free amines on an intact cell, allowing for the 
differentiation of live and dead cells (Perfetto et al. 2010). To ensure that all free 
amine groups were removed, the cells were washed twice with 1% wash buffer 
(150µl and 200µl for the first and second washes respectively) and the plate 
centrifuged at 2100rpm for 3 min. A total of 100µl of cytofix/cytoperm (Table 
S2) was added to the pellets and re-suspended. The plate was incubated at RT 
for 20 min. Permwash [BD Biosciences, Cat. No. 554723] (Table S2) was 
added twice to wash the cells as before and the plate centrifuged at 2100rpm 
for 3 min. A four colour panel anti-CD3 V450, anti-CD4 PerCP-Cy5.5, anti-CD8 
V500 and anti-CD45 APC (see table 2 below) was applied. An antibody 
mastermix was prepared using anti-CD3, anti-CD8 and anti-CD4 and anti-
CD45 before adding 100µl of antibody mastermix to the cell pellets. The plate 
was then incubated at RT for 20 min. The cells were washed twice as before 
and the plate centrifuged at 2100rpm for 3 min. To ensure the cross-linking of 




and protein, 200µl of cell fix was added to cell pellets and re-suspended before 
being transferred to labelled 5ml Falcon tubes (BD Biosciences). A further 100-
200µl of cell fix (Table S2) was added to the wells and contents added to falcon 
tubes. Samples were acquired within 24 hours of staining using the BD LSRII 
flow cytometer and data obtained was analysed using FlowJo analytical 
software version v.9.8.5 (Treestar, Ashland, OR). 
 





Company   Clone Titrated 
Volume 
 
         
CD3 V450 560365 BD Biosciences   OKT3 1µl  
CD4  PerCP-Cy5.5 560650 BD Biosciences   RPA-T4 1µl  
CD8  V500 560775 BD Biosciences   RPA-T8 1µl  











2.6.3 Preparation of compensation tubes 
A new set of compensation tubes were prepared for every experiment in order 
to prevent spectral overlap by using artificial latex beads. To create a positively 
labelled population, CompBeads come in a pair and consist of two microparticle 
populations, CompBeads anti-mouse Ig,ĸ (positive) and the CompBeads 
negative control. The positive microparticles bound to mouse ĸ chain 
immunoglobulins create the positive population. The negative CompBeads (BD 
Biosciences, Cat. No. 51-90-9001291) control have no binding capability, 
therefore are unable to bind to any antibody and forms the unstained 
population. Before addition of a single drop of negative and positive (BD 
Biosciences, Cat. No. 51-90-9001229) compbeads to individual FACS tubes 
containing 100µl PBS, the compbeads were vortexed thoroughly for about a 
minute to avoid clumping of the beads. The pre-determined volumes of anti-
CD3, anti-CD4, anti-CD8, anti-CD45 and anti-CD14 PacBlue (for compensation 
of Vivid) were added to their respective tubes and was incubated at 4°C for 20 
min. The beads were then fixed by adding 100µl of cell fix. Tubes were wrapped 




Tissue blocks stored at -80°C were transported on dry ice and 8-10μm thick 
sections were cut using a cryostat (Leica CM1850 Cryostat) (Fig 2.2B). The 
sections were placed onto microscope slides (Leica, Cat no. 38002e) with at 
least 3 sections per microscope slide. Slides were then stored for a short period 
of time at -80°C until staining. 
2.7.1 Foreskin cell staining 
Slides were taken from -80°C and allowed to warm up to RT for 10 min. To fix 
tissue sections, 4% paraformaldehyde solution (Santa Cruz, Cat no. SC-
281692,) was used to cover all sections on the slide for 10 min. The solution 
was dumped off the slide and washed twice in Coplin jars (Sigma Aldrich 
Product no. S5766) containing ice cold 1x PBS. The remainder of the solution 




block any non-specific binding, 2% Bovine Serum Albumin (BSA) (Santa Cruz, 
Cat no. sc-2323,) was added to slides and incubated for 30 min. The BSA was 
then poured off and the remainder of the liquid suctioned up. The tissue 
sections were then outlined using a hydrophobic pen (Leica, Cat. No. Z672548) 
to keep the antibody within the staining area. The primary antibody was then 
added, anti-langerin (Table 3) and incubated overnight at 4°C ensuring it was 
away from light. The wash step was repeated. A secondary antibody was added 
to detect the primary antibody, Rhodamine-Red (Table 3) for 30 min in the dark 
at RT. The wash step was repeated. A second primary stain was then applied 
using anti-Filaggrin (Table 3) with the use of Zenon kits (Table 3; Figure 2.3) as 
recommended by the manufacturer. Briefly, the Zenon kits allow the formation 
of a complex between an intact IgG antibody and a fluorophore directed against 
the Fc portion of the IgG. This eliminates non-specific binding and ensures the 
high affinity selectivity for the Fc portion of the corresponding antibody.  A 
master mix was prepared by adding 5µl of anti-filaggrin antibody to 5µl of Zenon 
Alexa fluor 647 reagent A, mixed and incubated in the dark for 5 min. To ensure 
there was no non-specific binding by unbound Fc portions, 5µl of Zenon 
blocking reagent B was added and incubated in the dark for 5 min. To make a 
dilution of 1:50, 758µl of PBS was added to the solution before being added to 
the slides and incubated in the dark for 1 hour. The solution was dumped off 
and washed twice in PBS and the remaining liquid suctioned up. In order to 
detect the nucleus of the cell, a 1:5000 dilution of Hoechst (Table 3) was added 
as a counterstain to the slides and incubated for 15-20 min in the dark. The 
wash step was repeated. A small drop of fluorescent mounting medium (Sigma, 
Cat no. F4680) was added to each tissue and a coverslip (Leica, Cat. no. 
14071135635) was then placed on the slides ensuring no air bubble formations. 
This was allowed to dry for 5 min before sealing the edges of the coverslip with 
fast drying clear nail polish. After ensuring that the nail polish was dry, slides 
were stored in slide boxes (Leica, Cat. No. 71459-B) and stored at 4°C until 







Figure 2.3: Zenon kit labelling: The Zenon fragments were specifically 
designed to target and bind to the Fc portion of the primary antibody only to 
allow for rapid, noncovalent labelling of small quantities of primary antibody 





It should be noted that the CCR5 antibody used for IHC staining was kindly 














































































































































































































































































































































































































































































































































































































2.7.2 Confocal Imaging 
Images of tissue sections were taken on the Zeiss LSM510 Meta with Non-
Linear Optical (NLO) confocal using the following lasers: An Argon Green 
emission with excitation at 488 nano meter (nm), A Solid state laser Red 
Emission with excitation at 561nm excitation, A HeNe laser Far red emission 
with excitation at 633nm and it has a two photon laser for ultra violet excitation 
and detection of the nuclear stain at 750nm. All voltages were constant for all 
images taken. The red laser has a Bandpass (BP) 575-630 Infrared (IR) filter, 
the far red laser has a BP 650-710 IR filter and the ultra violet laser has a BP 
390-465 IR filter. The purpose of the filter is to allow all wavelengths in between 
the specified filter range (eg. BP 575-630 would allow all wavelengths between 
575nm and 630nm to pass through) and infrared light to pass through, while all 
other wavelengths are reflected. Images for CD4/Ki67 and CCR5/CD4 were 
collected using the oil objective at 63x magnification and CD207/Filaggrin was 
collected using the water objective at 40x magnification. The number of Z-
sections varied from section to section, with the z-sections being 0.98µm apart 
and an average of five images collected per slide.  To facilitate imaging of larger 
areas of tissue, tile scanning was performed by stitching of 3x3 separate 
images (or tiles) for CD4/Ki67 and CCR5/CD4 while 3x2 tiles were stitched 




2.8 Data analysis 
2.8.1 Flow Jo 
All samples were acquired on the LSRll flow cytometer ensuring that all 
photomultiplier tubes (PMT) voltages were adjusted according to quality control 
checks and compensation matrices. Flow cytometry analysis was then 
performed using FlowJo analytical software version v.9.8.5. (Treestar, Ashland, 
OR) The following gating strategy was applied (Figure 2.4).   
 
Figure 2.4: Gating strategy from a foreskin sample applied to FlowJo 
analysis 
 
2.8.2 Fiji and Integrative Data language 
To ensure the optimal and accurate analysis of the images captured, images 
were analysed using Just ImageJ (Fiji) software imaging version 2.0.0-rc-
23/1.49m (GNU General Public License v3, open source) to utilize captured Z-
stacks where necessary to ensure counting positive staining events and aid in 
the quantitative application of integrative data language (IDL) version 7.1.1 with 
X11 (XQuartz-v2.7.7).  Z-stacks combines multiple images taken at different 
focal distances to provide a composite image with a greater depth (Ray., 2002), 
enabling clearer vision of cells that were imaged. IDL is a scientific 
programming language used in the analysis and visualisation of 
multidimensional data sets. Using an IDL generated algorithm (Table S1), LCs 
(CD207+) and keratin layers (Filaggrin+) were measured as follows (Figure 
2.5):  lines K1 (outer keratin layer) and K2 (inner keratin layer) were drawn 
carefully using a mouse and the LCs were marked using the mouse by clicking 




automatically drew lines between K1 and K2 as well as lines from K2 to all LCs. 
The measured distances were automatically generated in summarised excel 
spreadsheets. A minimum of 5 images for both the inner and outer foreskin was 
taken and the averages from these images were used for data analysis. The 
same analysis was applied and another algorithm used to analyse the 
CD4/Ki67 images with the line K1 drawn and the CD4 and Ki67 cells marked 
using the mouse. Cell numbers were calculated using a cell density formula 
(Table S1). 
 
Figure 2.5: IDL image analysis. A) An image before analysis using IDL. The 
keratin layer, stained using anti-filaggrin (red), LCs stained using anti-langerin 
(green) and nuclei stain using dapi (blue). B) An image that has been 
analysed using IDL. Line K1 (green) represented the outer layer of keratin of 
the epidermis.  Line K2 (red) demarcated the separation between the bottom 
keratin layer and the epidermal cells.  LCs were counted by placing a 






2.9 Statistical analysis 
All the statistical analyses were performed using GraphPad Prism 5® 
(GraphPad Software, San Diego California USA). The non-parametric Mann-
Whitney U test was used for unpaired data. Paired t-test was used for the 
comparison of matched data. The Spearman rank correlation test is a statistical 
measure of the strength between two continuous or ordinal variables. This is 
based on the ranked values for each variable rather than the raw data. The 
Pearson test is a statistical measure of a correlation between two continuous 




B. Optimisation for Flow Cytometry and Immunohistochemistry  
 
All protocols used in the optimisation of techniques were novel to this 
dissertation. Table 4 shows a summary of the different experiments carried out 
to optimise the number of viable cells isolated from foreskin tissue. Fresh 
samples were used for all experiments unless it was stated that frozen samples 
were used. All tissues used were of equal quantity. The same participant was 
used for all experiments except where fresh tissue was compared to frozen 
tissue. The time period for storage of frozen samples was not recorded (Figures 
2.5; 2.7; 2.9; 2.11). The purpose of optimisation experiments was to ensure 
there was an optimal yield of viable cells from the foreskin. We first optimised 
the type of collagenase, collagenase A (Life Technologies) and collagenase B 
(Sigma Aldrich) used to determine which would facilitate the digestion of 
foreskin tissue effectively to get the maximum number of viable cells. Next we 
determined the optimal concentration of collagenase to use to digest the 
foreskin tissue as well as test if the use of scissors or an automated machine 
aided tissue digestion. The purpose of the next experiment was to determine if 
digesting fresh tissue compared to frozen tissue yielded a greater amount of 
viable cells. Table 5 shows a summary of the different antibody dilutions that 
were optimised in order to stain the foreskin for cells using 
immunohistochemistry. The purpose of the experiments was to determine the 
optimal concentration of antibody that gave the brightest signal upon cell 
staining.  We first optimised the anti-CD4 antibody to visualise CD4+ resident 
T cells present in the foreskin. Next we stained using anti-Ki67 with the use of 
Zenon kits and a secondary detection antibody, Alexa647 to determine if the 
use of the Zenon kit or secondary antibody facilitated a better detection of Ki67. 
Thereafter, we optimised the staining dilution for anti-CCR5 as this is a known 
co-receptor for CD4. Lastly, we optimised the staining dilution for anti-CD209 
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The first set of optimisation experiments comparing Collagenase A and B 
showed that collagenase A was able to yield a higher percentage of viable cells 
(39.3%) compared to that of collagenase B (18.5%) (Figure 2.5). Figure 2.6 
shows that collagenase A had a higher yield of CD3+ and CD4+ T cells while 
collagenase B had a higher yield of CD8+ T cells.   
The second set of optimisation experiments compared Collagenase A at 
concentrations of 62U/ml, 125U/ml, 250U/ml and 500U/ml using scissors and 
the BD medimachine to aid in digestion. The highest concentration (500U/ml) 
was most effective and yielded the highest percentage of viable cells, 16.7% 
and 14.9% for the BD medimachine and scissors respectively (Figure 2.7C and 
2.7D) compared to 1.08% and 0% of viable cells at the lowest concentration 
(62U/ml) for BD medimachine and scissors respectively (Figure 2.7A and 2.7B). 
Figure 2.8 shows the yield of cells at various concentrations. At a concentration 
of 62U/ml, there were extremely low yields of cells in the inner foreskin when 
using both methods of mechanical digestion and low yields in the outer foreskin 
when using the medimachine. There were less than 40% of CD3 and CD4 cells 
and approximately 60% of CD8 in the outer foreskin when using scissors. At a 
concentration of 125U/ml, yields of viable, CD3, CD4 and CD8 cells in the inner 
foreskin were 0% regardless of mechanical digestion method used with low 
yields of live and CD3+ cells in the outer foreskin. At a concentration of 
250U/ml, there were better yields of CD4 and CD8 cells using both mechanical 
digestion methods. Although, viable and CD3+ cell yield was still low. The use 
of scissors however, yielded more viable cells, CD3 and CD4 cells in the inner 
foreskin compared to use of the medimachine. At a concentration of 500U/ml, 
the yield of viable cells in the inner foreskin was slightly higher by use of the 
medimachine. The use of scissors however yielded approximately double the 
amount of CD3+ cells compared to the medimachine. The use of the 
medimachine yielded no CD8 cells in both the inner and outer foreskin and 
while the yield of CD4+ cells were 100%, this may be due to the low yield of 
CD3 cells and placement of the gate in FlowJo. 
The third experiment was to optimised the tool used to aid in tissue digestion at 




yielded 0.206% of viable cells compared to 14.3% of viable cells for scissors 
(Figure 2.9A and 2.9B). Figure 2.10 shows that the use of scissors is better 
suited in the digestion of tissue as there was a greater yield of viable and CD4 
cells in the inner and outer foreskin, and a greater yield of CD3 and CD8 cells 
in the inner foreskin compared to the use of the medimachine. 
The last set of optimisation was to determine whether using the optimised 
techniques above worked better for fresh or frozen samples. The use of fresh 
tissue showed a greater yield of CD3+ cells (57.6%) and (49.75%) in the inner 
and outer foreskin respectively compared to the use of frozen tissue where 
CD3+ cells accounted for 27.3% and 60.9% in the inner and outer foreskin 
respectively (Figure 2.11A and 2.11B). Figure 2.12A shows the yield of viable 
cells using the TC20. The median yield of viable cells in the inner foreskin from 
frozen tissue is higher than from the fresh tissue (44% and 26.5% respectively) 
while the median yield of viable cells in the outer foreskin from frozen tissue is 
lower than from fresh tissue (12% vs 44% respectively). The average amount 
of viable cells however, did not differ by much, with 32.14% and 38.85% of 
viable cells for fresh and frozen tissue in the inner foreskin respectively while 
the average yield of viable cells in the outer foreskin of fresh tissue was almost 
double the amount in frozen tissue (40.29% and 22.08% respectively). Another 
factor that may have contributed to the higher percent of viable cells in frozen 
samples may be due to the total amount of live cells used in the TC20 cell 
counter. The average amount of live cells used in fresh tissue samples were 
2.26 x 106 cells in the inner foreskin and 2.07 x 106 cells in the outer foreskin 
compared to 2.95 x 105 cells in the inner foreskin and 3.02 x 105 cells in the 
outer foreskin of frozen tissue samples. Due to the low yield of cells 
experienced in some frozen samples where there was >80% of dead cells, we 
did not deem it logical to conduct flow cytometry on all of these samples. Figure 
2.12B shows the percentage of CD45+, CD3+ and CD4+ cells in the inner and 
outer foreskin from fresh tissue samples. There is a higher yield of CD45 and 
CD3+ cells in the inner compared to the outer foreskin, while the outer foreskin 
has a higher yield of CD4+ T cells. There is a median yield of approximately 




Finally, we optimised the amount of antibody used for immunohistochemistry 
staining. The CD4 dilution worked best at 1:100 (Figure 2.13), the use of the 
Alexa647 goat-anti mouse secondary antibody allowed for better detection of 
KI67 than the Zenon kit (Figure 2.14), the CD209 stain worked best at 1:200 
(Figure 2.15) and lastly, the CCR5 stain worked best at 1:10 (Figure 2.16) 
dilution. Figure 2.17 shows cell density of the various stains at different 
dilutions. There were 4 samples used in the optimisation of CCR5 (Figure 
2.17A) with median cell densities of 3.5, 9.5 and 2.5 for the 1:5, 1:10 and 1:20 
dilutions respectively. There were 8 samples for Ki67 (Figure 2.17C) with 
median cell densities of 1 and 23 for Zenon kit and Alexa647 respectively. 
There were 2 samples for CD4 with median cell densities of 10, 6.5 and 7.5 for 
1:100, 1:200 and 1:400 dilutions respectively. There were 2 samples for CD209 
with median cell densities of 21.5, 33.5 and 2 for 1:100, 1:150 and 1:200 
dilutions. The best dilution was chosen based of brightness of fluorescence and 
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Confocal microscopy enables microscopic visualization of subsurface 
structures and the ability to section tissue pieces allows for the capturing of an 
intact tissue (Minsky 1957; Aspres et al. 2003). A tissue piece may also be 
imaged multiple times over a time period to examine any tissue changes due 
to the non-invasive nature of confocal microscopy (Aghassi et al. 2000). 
Confocal microscopy allows for development of specific techniques that enable 
the visualisation of structure, function and dynamics of the skin in vivo with the 
use of fluorescent markers (Anikijenko et al. 2001). Due to the development of 
these techniques, it has allowed studies to characterise the different layers of 
the skin such as the keratin, epidermal and dermal layers (Swindle et al. 2003). 
A thick keratin layer of the epidermis has been thought to provide a more robust 
barrier of protection in the foreskin (Candi et al. 2005). Within the epidermal 
and dermal layer, immune cells such as LCs and CD4+ T cells have been 
observed in the foreskin and are potential targets for HIV-1 infection (Liu et al. 
2014). LCs are thought to be the first immune cells to encounter HIV-1 
(Patterson et al. 2002; Kawamura et al. 2005) and a small population of CD1a 
positive LCs are positive for CD4 expression (Lynch et al. 2003). The main 
target for establishing a productive HIV-1 infection, CD4+ T cells are also 
present in the dermis of the foreskin (Patterson et al. 2002; Donoval et al. 2006). 
There have been disparate finding with regards to the numbers of immune cells 
present in the foreskin. There were 4 groups that have found different results, 
Liu et al., found a greater number of LCs and CD4+ T cells in the inner 
compared to the outer foreskin, Patterson et al., and Lemos et al., found more 
CD4+ T cells in the inner compared to the outer foreskin while McCoombe & 
Short found more CD4+ T cells in the outer compared to the inner foreskin. 
Donoval et al., showed that the CD4+ T cells are found deep in the tissue and 
are therefore not likely the first cells to come into contact with HIV-1 and that 
STIs may increase the risk of HIV-1 infection, in particular the ulcerative STIs.  
There may be some factors that are elevating the numbers of HIV-1 target cells 
that are present in the foreskin and one of these are STIs. Symptomatic STIs 
such as syphilis causes painless genital ulcerations, but is associated with the 




and asymptomatic STIs such as HSV, which is able to increase the numbers of 
CD4+ T cells expressing CCR5 in the foreskin (Shannon et al. 2014; Prodger 
et al. 2012). STIs have been strongly associated with the increased risk of HIV-
1 infection (reviewed by Ward & Rönn 2010). The presence or history of a 
genital ulcerative diseases (GUD) such as NG, TV (reviewed by Fox & Fidler 
2010), HSV-2, which is the most common GUD around the world (Morse 1999) 
and MG (Mavedzenge & Weiss 2009) is able to increase the per-act infectivity 
of HIV-1 five-fold compared to individuals with no STI (reviewed by Boily et al. 
2009) due to inflammation, trauma and increased number of target cells to the 
site of infection (Shannon et al. 2014; Prodger et al. 2012; Johnson et al. 2009). 
A systematic review by Dunne et al., found that ≥20% of asymptomatic men 
have detectable HPV DNA in anogenital areas. HPV is one of the most 
prevalent STIs in the world and men with a HPV infection are three times as 
likely to contract HIV-1 compared to a HPV negative man (Rositch et al. 2014). 
Johnson et al., showed that HSV-2 infection in men increases the CD4+ cell 
density in the foreskin. Donoval et al., showed that there were a greater 
numbers of LCs in the foreskin of STI+ compared to STI- men whereas Hussain 
& Lehner., found no differences in the number of LCs and CD4+ cells in the 
foreskin.  
 
3.2 Cohort Characteristics 
We selected a subset of 28 age-matched STI+ and STI- individuals from the 
Edendale cohort for IHC staining. No men from the CHB cohort were selected 
for IHC staining. The median age of the men was 19 years (range 15-24). The 
subset consisted of 17 STI+ individuals (Figure 3.1) and 11 STI- individuals. 
The following STIs were screened for: N. gonorrhea (NG), C. trachomatis (CT), 
T. vaginalis (TV), M. genitalium (MG), HSV-1 and HSV-2. CT was the most 
prevalent STI in the cohort, accounting for as much as 70% of STIs (Table 6). 
There were 3 individuals from the CHB site that were STI+ (7.3%) with 2 of the 
individuals testing positive for CT.  We also tested for testosterone in the 
individuals from the EDH site to evaluate the differences in testosterone levels 



















































































































































































































































































































































































































































































































3.3 Differences in keratinisation levels between inner and outer foreskin 
To investigate differences in the degree of keratinisation between the inner and 
outer foreskin, anti-filaggrin was used to stain the keratin layer in the subset of 
participants. Filaggrin was used as it is a filament-associated protein that binds 




Figure 3.2: Annotation of image generated by confocal microscopy. A) 
The keratin layer is shown by the filaggrin (Alexa 647) stain in red and is 
demarcated from the epidermis by the white dotted line. The LCs’ cells 
represent the CD207 (Cy3) stain in green and the nuclei represents the dapi 






In this dissertation, we compared the thickness of the keratin layer (8.3873 vs 
6.674µm in the outer and inner foreskin, p=0.0058) and found that the outer 
foreskin was 1.712μm thicker than the inner foreskin, which is in agreement 
with findings by Patterson et al. 2002; McCoombe & Short 2006 and Ganor & 
Bomsel 2011 (Figure 3.3B). We then analysed the degree of keratinisation in 
context of asymptomatic STI status and found that there were no significant 
differences in the degree of keratinisation in the inner (6.8100 vs 6.5050µm in 
STI+ vs STI- men, p=0.8538) or outer (8.4282 vs 8.0780 in STI+ vs STI- men, 










































































































































































3.4 Langerhans Cells 
Langerin is a C-Type lectin expressed in LCs. In order to quantify the number 
of LCs, we used anti-langerin antibody to stain for langerhans cells present in 
the inner and outer foreskin. The LCs were found to be present in the epidermis 
of the inner and outer foreskin consistent with findings by Qin et al., who also 
showed that the majority of LCs were found in the epidermis (Figure 3.4). 
 
 
Figure 3.4: Confocal Images of Filaggrin and Langerhans’ cell stains. A) 
Image of fillagrin (red), langerhans cell (green) and dapi (blue) staining in the 
inner foreskin of a STI negative participant. B) Image of fillagrin and 
langerhans cell staining in the inner foreskin of a STI positive participant. C) 





There were no significant differences in Langerhans cell density (2.5 vs 3.5 
cells/mm2 in inner vs outer foreskin; Figure 3.5A). We then analysed the 
Langerhans’ cell density in context of the asymptomatic STI status. There was 
a significantly higher number of LCs present in the foreskin of men with STIs in 
both the inner (3.3 vs 0.3 cells/mm2 in STI+ vs STI- men, p<0.0017) and outer 


























































































































































3.5 CD4 and Ki67 
CD4+ T cells are a major target for HIV-1 infection and Ki67 is a proliferation 
marker. We used anti-CD4 and anti-Ki67 to stain the inner and outer foreskin 
tissue to determine the density of CD4+ T cells and Ki67+ cells present in the 
inner and outer foreskin tissues (Figure 3.6).  
 
 
Figure 3.6: Confocal images of a STI negative and positive individual 
that have been split into CD4 and Ki67. A) STI- images of CD4 (left) and 





There were no significant differences in the number of CD4 (4.4 vs 2.7cells/mm2 
in inner and outer foreskin; Figure 3.7A) and Ki67 (3.8 vs 3.2 cells/mm2 in inner 
and outer foreskin; Figure 3.7A) cells. We then analysed the CD4 and Ki67 cell 
densities in context of asymptomatic STI status. We found no significant 
differences in the number of CD4 cells in the inner (4.9 vs 4.3 cells/mm2 in STI+ 
and STI- men, p=0.5402) and outer (2.2 vs 3.5 cells/mm2 in STI+ and STI- men, 
p=0.9624) foreskin. There were no significant differences in the number of Ki67 
cells in the inner (3.5 vs 3.8 cells/mm2 in STI+ vs STI- men, p=0.7233) and outer 
(1.6 vs 3.8 cells/mm2 in STI+ vs STI- men, p=0.5394) foreskin. (Figure 3.8B and 
Figure 3.8B respectively). Although there were no significant differences in the 
number of CD4 T cells in the inner and outer foreskin, CD4 T cells were present 
in high numbers in the epithelial tissue indicating that these cells are able to 
move to non-lymphoid tissue. The Ki67+ cells present in the foreskin are 























































































































































































































































































































































































































































3.6 Distance of Immune cells from epithelium 
Immune cells are present in the epidermis and dermis of the foreskin and have 
the potential to migrate. We therefore quantified the distance of LCs present in 
the inner and outer foreskin from the epithelium (Figure 3.2).  
In this dissertation, we found a significant difference in the distance of LCs from 
the epithelium (99.19 vs 75.25 µm in the inner and outer foreskin, p<0.0001; 
Figure 3.10A) with a median difference of 23.922μm. Next we analysed the 
distance of LCs in context of STIs and found that there were no significant 
differences between the inner foreskin of STI+ and STI- individuals. We did 
however find that median distance of LCs was significantly closer to the 
epithelium in the outer foreskin (68.19 vs 83.608µm in STI+ vs STI- men, 
p=0.0385; Figure 3.10B) with a median difference of 15.418µm, suggesting that 
these cells are closer to the epithelium in the outer foreskin of STI+ individuals. 
The position of these cells could predispose them to a greater risk of infection 
during an HIV-1 transmission event. Next, we measured the distance of CD4+ 
cells from the epithelium in the inner and outer foreskin (168.5µm and 155.1µm 
respectively) regardless of STI status and found no significant difference 
between the inner and outer foreskin (Figure 3.11A). Lastly, we measured the 
distance of CD4+ cells in the inner and outer foreskin of STI+ and STI- 
individuals. There were no significant differences in the distance of CD4+ cells 
from the epithelium in the inner and outer foreskin of STI+ compared to STI- 
individuals (Figure 3.11B). Although there were no significant differences 
observed in the distance of CD4+ cells from the epithelium, the CD4+ T cells 
are further away from the epithelium compared to LCs and are therefore less 


























































































































































































































































































































































There are up to 80% of adults that are infected with HIV-1 through genital mucosal 
surface exposure to the virus (UNAIDS 2010). The sexual transmission of HIV-1 in 
men are acquired mainly through the penis (Boily et al. 2009). Direct mucosal 
disruption leading to a compromised barrier integrity (reviewed by Ward & Rönn 2010) 
and the thinner keratinised layer of the foreskin is believed to play a role in HIV-1 
acquisition as HIV-1 is able to enter the foreskin easily (Ganor et al. 2010). Other 
factors that influence the risk of HIV-1 acquisition such as STIs, especially ulcerative 
STIs (reviewed by Ward & Rönn 2010) and a larger foreskin surface area (Kigozi et 
al. 2009) may increase the number or target cells present in the foreskin, which in turn 
may impact HIV-1 acquisition. Furthermore, young people between the ages of 14-24 
bear an enormous burden of the HIV-1 pandemic and at least 40-50% of all new HIV-
1 infections among adults may occur in the young population (Unaids 2015). 
Therefore, the aim of this study was to examine the immunological cellular composition 
and levels of keratinisation in the inner and outer foreskins after medical male 
circumcision as well as to characterise the number and position of LCs and CD4+ T 
cells within the inner and outer foreskin in young men between the ages of 14-24.  
de Vincenzi & Mertens., proposed that keratinisation of the penis may provide an 
impermeable barrier to HIV-1, thus making it an unlikely source for primary infection 
unless it has been compromised by lesions, micro-trauma as well as inflammation. 
The variability of the keratin thickness between individuals may vary depending on 
epithelial cell differentiation and regulation of structural protein expression levels which 
is dependent on both physical and environmental factors (Dinh et al. 2012). 
Mechanical stress such as the act of sexual intercourse may introduce abrasions in 
the keratin layer and alter keratinisation of the foreskin. Other factors that may impact 
keratinisation is the type of environment the foreskin is exposed to. The outer foreskin 
is exposed to an aerobic environment whereas the inner foreskin has an anaerobic 
environment (O’Farrell et al. 2006; Price et al. 2010). The results of this dissertation 
show that the outer foreskin keratin layer was significantly thicker by 1.712 µm than 
the inner foreskin. These results are consistent with findings by Patterson et al., 
McCoombe & Short  as well as Ganor & Bomsel who also found the keratin layer in 
the outer foreskin to be thicker than that of the inner foreskin. In contrast, two studies 




and outer foreskin (Dinh et al. 2010; Dinh et al. 2012). The differences in keratin 
thickness that are seen by the different study groups could be due to ethnic origin or 
sexual behaviour. The subpreputial epithelial that covers the inner foreskin comprises 
of moist epithelia which may make it more susceptible to HIV-1 infection due to the 
thinner, more permeable keratin layer as seen by the findings reported in this 
dissertation and findings by recent studies (McCoombe & Short 2006; Patterson et al. 
2002; Anderson, J. A. Politch, et al. 2011), whereas the thicker keratin layer in the 
outer foreskin may provide a more robust barrier to HIV-1 viral entry compared to the 
inner foreskin. There are currently no studies that look at the environmental effect on 
the degree of keratinisation in the inner and outer foreskin. This may be important due 
to the change of the penile environment upon circumcision and its effects on 
keratinisation of the glans of the penis. The thicker keratinised layer may provide 
protection against HIV-1 acquisition, although, the complete removal of the foreskin 
would eliminate the susceptibility of less keratinised layer as seen in the inner foreskin. 
The foreskin has been shown to harbour many target cells for HIV-1 infection. These 
cells include LCs and CD4+ T lymphocytes which are targets for HIV-1 infection 
(Hussain & Lehner 1995; Donoval et al. 2006; McCoombe & Short 2006; Patterson et 
al. 2002). The results in this study show that there were no significant differences in 
the number of LCs, CD4+ and Ki67 cells present in the inner and outer foreskin, where 
the LCs were mostly present in the epithelium of the foreskin, consistent with findings 
by Donoval et al. Although there were no significant differences in the number of LCs 
and CD4+ T cells in the inner and outer foreskin, these cells play a critical role in HIV-
1 infection. CD4+ T cells are known targets of HIV-1 and the presence of these 
immune cells in the foreskin may elevate the risk of HIV-1 acquisition. (Prodger et al. 
2012), showed that the proportion of CD4+CCR5+ T cells were up to four times higher 
in the foreskin compared to the blood. This could potentially enhance susceptibility to 
HIV-1 infection. LCs have been shown to express low levels of CD4 and are 
susceptible to infection with HIV-1 (Kawamura et al. 2003; Turville et al. 2002; Zaitseva 
et al. 1997). The productive infection of LCs may allow the transfer of the virus to CD4+ 
T cells thus increasing the risk of HIV-1 infection (Sarrami-Forooshani et al. 2014; 
Kawamura et al. 2003; de Witte, Nabatov & Geijtenbeek 2007; reviewed by McDonald 
2010). Although, a study by de Witte, Nabatov, Pion, et al., in  2007 showed that 




if langerin was not blocked by an antibody or mannan, suggesting that LCs play a 
protective role in HIV-1 infection as well as serve as targets for HIV-1 infection. These 
experiments have been conducted in vitro and the relative importance in vivo needs 
to be investigated. In addition, a study by Geijtenbeek et al., shows that DC-SIGN is 
able to recruit and facilitate HIV-1 infection of CD4+ T cells in vitro. 
One of the major factors increasing HIV-1 susceptibility is a concomitant infection with 
an STI.  In this study we tested all participants for a panel of 6 asymptomatic STIs (N. 
gonorrhea, C. trachomatis, T. vaginalis, M. genitalium, HSV-1 and HSV-2) and a 
subset for HPV infection. This allowed us to investigate our results in the context of 
asymptomatic STI status. We found that asymptomatic STIs have no significant impact 
on the degree of keratinisation in the inner or outer foreskin, suggesting that underlying 
local inflammation caused by STIs may not be playing any role in keratin deposition in 
the foreskin. 
Next, we focused on LCs, CD4+ and Ki67+ cells. In the literature, there are 
contradictory results regarding the numbers of HIV-1 target cells in the inner and outer 
foreskin, with some studies reporting more target cells in the inner foreskin (Ganor et 
al. 2010; Patterson et al. 2002; Donoval et al. 2006; Fischetti et al. 2009; Liu et al. 
2014) while others reporting more cells in the outer foreskin (McCoombe & Short 2006; 
Qin et al. 2009). We found that there was a significant difference in the number of LCs 
present in the inner and outer foreskin of STI+ compared to STI- individuals, this was 
similar to findings by Donoval et al., who had observed a higher number of langerhans 
cell in individuals with an asymptomatic STI compared to those without a STI. We 
found that LCs were predominantly present in the epidermis of the foreskin. This is not 
surprising as these are the first immune cells to come into contact with invading 
pathogens (Patterson et al. 2002; Kawamura et al. 2005) and LCs have dendrite like 
appendages that sample the environment for antigen presentation to T cells. This 
suggests that the presence of an STI may play a role in the number of LCs found in 
the epidermis of inner compared to the outer foreskin. Furthermore, the type of STI 
present had no effect on the number of LCs present in the foreskin. We found no 
significant differences in the number of CD4+ and Ki67 cells present in the inner and 
outer foreskin of STI+ and STI- individuals similar to findings by Donoval et al., who 
had also reported no differences in the number of CD4+ T cells regardless of STI 




CD4+ cells in the inner compared to the outer foreskin, although there was no 
significant difference. Although we saw no differences in the number of CD4+ T cells, 
these cells were present in high numbers with clear clumping around vasculature. 
CD4+ T cells are the primary targets for HIV-1, the presence of these cells at high 
densities in the foreskin as shown by our study suggests that this may increase the 
risk of HIV-1 infection in men. The high density and clumping of CD4+ T cells in the 
dermis that we observed may make them easier targets for productive infection with 
HIV-1 upon antigen presentation by a LC carrying a HIV-1 virion. The presence of 
CD4+ T cells in high numbers also suggests that these cells are able to move to non-
lymphoid epithelial tissue. This study also shows that the proliferating cells are not 
CD4+ T cells.  
Lastly, we looked at the position of LCs and CD4+ T cells within the foreskin tissues 
assayed as the position of these cells within the epithelium may make them more 
susceptible to infection upon HIV-1 entry. The position of these cells may place them 
at a greater risk of being infected with HIV-1, this also implies that in the presence of 
a STI, LCs are more concentrated near the epidermis of the outer foreskin. The high 
numbers of LCs in the epidermis also poses an increased risk of HIV-1 infection.  A 
study by Ganor et al., of an in vitro model showed that the inner foreskin was 
preferentially infected with HIV-1 infected cells. The formation of viral synapses and 
HIV-1 particle budding was followed by internalisation by LCs which migrated to the 
dermal layer and formed LC-T cell conjugates where HIV-1 was transferred to T cells. 
We postulate based on in vitro models in two studies that HIV-1 is able to preferentially 
infect LCs and CCR5 expressing CD4+ T cells in the inner foreskin (Patterson et al. 
2002) and that R5 specific HIV-1 strains infects foreskin as well as other tissues such 
as the glans, urethral tissue and meatus equally (Fischetti et al. 2009). Although the 
presence of these cells increases the number of targets for HIV-1, two studies have 
shown the protective effect of LCs. The study by Sarrami-Forooshani et al., used an 
ex vivo tissue model and showed that LCs transmitted R5 specific HIV-1 and restricted 
transmission of X4 specific LCs. Taken together, LCs may play an important role in 
the protection and prevention of transmission of HIV-1 to T cells. This however is 
limited to a low viral load as a higher viral load at the foreskin may overwhelm the 
protective function of LCs and lead to infection (Ganor et al. 2010). It is therefore 




genital tract are characterised as well as identify the roles as well as susceptibility to 
infection of CD4+ T cells and LCs in the genital tract. In this study, there were no 
significant difference between the distances of CD4+ T cells from the keratin layer to 
the position they were found within the inner compared to the outer foreskin. We did 
however find a significant difference in the distances of LCs from the outer keratin 
layer in the foreskin regardless of STIs. We measured the distances of LCs in context 
of STI status and found no significant differences between the inner foreskin of STI+ 
and STI- individuals. However, there was a significant difference in the distances of 
LCs to the outer keratin layer in the outer foreskin of STI+ compared with STI- 
individuals. There was a pronounced significant reduction in the median distance of 
LCs in the outer foreskin of STI+ individuals, suggesting that these cells have moved 
closer to the epithelium. Our group has shown a positive correlation between CCL27 
and LCs (unpublished data), this may explain the recruitment of LCs to the epithelium 
of the foreskin making them susceptible to HIV-1 infection.  
The presence of a STI may enhance the number of HIV-1 target cells present in the 
foreskin tissue, therefore, this creates a greater risk for HIV-1 acquisition and therefore 
onward transmission to sexual partners. Co-infection with an asymptomatic STI has 
been identified as a primary driver of inflammation in the genital tract and is involved 
in the recruitment of HIV-1 target cells to the foreskin tissue (Prodger et al. 2014; 
Freeman et al. 2006) and HIV-1 transmission has been shown to be elevated in 
circumstances where individuals have an asymptomatic and symptomatic STI 
infection (reviewed by Vermund 2007; reviewed by Ward & Rönn 2010). Although we 
saw differences between the control and STI+ group, some of the control participants 
may have had an asymptomatic STI that was not screened for. This may explain some 
of the high numbers of LCs and CD4+ T cells seen in STI- individuals. Fleming & 
Wasserheit., have shown that STIs, predominantly ulcerative STIs increases the risk 
of HIV-1 infection. The presence of asymptomatic STIs may be elevating the risk of 
HIV-1 acquisition in males and this may be a result of recruitment of immune cells due 
to inflammation in the foreskin, therefore the immune cells present serve as targets for 
HIV-1 infection. Asymptomatic STIs may be overlooked as the factor driving foreskin 
inflammation in the MGT and a study by Lemos et al., highlights the risk of 
inflammation in the foreskin. Lemos et al., show that the inflammatory milieu in the 




epidermis. This event may position the HIV-1 target cells in the epidermis where HIV-
1 entry and infection is facilitated. It is clear that infection with an asymptomatic STI 
may likely increases the risk of HIV-1 acquisition. However, the effects of 
asymptomatic vs symptomatic STIs on cell numbers need to investigated in order to 
determine which of these types of STIs pose a greater risk. CT was the most prevalent 
STI amongst the STI+ group with many individuals positive for CT across all age 
groups in addition to other STIs and CT is representative of the most common bacterial 
STI globally (Cook et al. 2005). Immunologically, CT increases HIV-1 shedding in the 
genital tract due to the recruitment of HIV-1 target cells such as CD4+ T cell due to 
the inflammatory response against CT (Fleming & Wasserheit 1999; Buckner et al. 
2016), thereby increasing the chance of HIV-1 infection in CT+ individuals. HPV is the 
most common sexually transmitted virus and it is most prevalent amongst young 
individuals after their sexual debut (Burchell et al. 2006; Dunne et al. 2006). In our 
cohort, there were a total of 7 in the STI+ and STI- group that tested positive for HPV. 
HPV has been shown to increase the risk of HIV-1 acquisition in men that have a 
recently cleared or persistent HPV infection (Rositch et al. 2014). Rositch et al., 
showed that the immune-regulatory mechanism that is associated with HPV clearance 
may also facilitate HIV-1 acquisition. This suggests that even though a man is being 
treated for the HPV infection, during this time he is still at an increased risk of HIV-1 
acquisition. This study suggests that STI status may play a vital role in the number of 
HIV-1 target cells present in the foreskin, furthermore circumcision has been shown to 
protect against HPV by up to 35% (Tobian et al. 2009; Tobian et al. 2010). 
In summary, these results show that the outer foreskin is more keratinised than the 
inner foreskin and asymptomatic STIs may play a role in elevating the risk of HIV-1 











Circumcision has been shown to decrease HIV-1 infection by up to 60% and this is 
possibly due to the removal of potential target cells as well as an inflamed environment 
that recruits possible HIV-1 target cells to the foreskin surface yet, globally, there are 
70% of the men that remain uncircumcised (WHO & Unaids 2007).  In areas of South 
Africa like Kwa-Zulu Natal, there is a misconception about the protective effect of 
circumcision and communities may not have a scientific understanding of this and 
would therefore engage in increased risky sexual behaviour (Milford et al. 2016). In 
mainly the Eastern Cape of South Africa, there are currently, 52.2% of males that 
undergo traditional circumcision while 51.6% of males aged 14-24 undergo medical 
male circumcision (Shisana, O, Rehle, T, Simbayi LC, Zuma, K, Jooste, S, Zungu N, 
Labadarios, D, Onoya 2014). Circumcision that occurs in non-clinical setting can result 
in the death of an individual (Peltzer et al. 2008). Furthermore, traditional circumcision 
does not fully remove the foreskin and there is need for re-circumcision at a medical 
facility which could result in the excessive removal of skin and deepened wounds 
(Wilcken et al. 2010). A study by Hoffman et al., in South Africa found that 26% of 
individuals circumcised for improvement in hygiene and health benefits, 37% for 
cultural or religious reasons, 11% were children circumcised due to parents’ decision 
and 26% did not provide any reason for circumcision. There were 71.8% of men that 
knew of at least one health benefit of circumcision while 28.2% knew of none, although 
only had any knowledge of the reduced risk in HIV-1 (Hoffman et al. 2015). South 
Africa has reached a total of 1.8 million MMCs by 2014 and the continued scale up will 
help achieve the 80% target of 4.3 million MMCs by 2016 (WHO 2015). Circumcision 
has also been shown to reduce the chances of acquiring STIs which in turn reduces 
the chances of HIV-1 acquisitions. WHO and UNAIDS have already called for the scale 
up of circumcision as a preventative measure against HIV-1 in men. Circumcision has 
also been shown to have protective effects for female partners, such as reduced risk 
of cervical cancer, decrease in HPV infection, BV and TV in female partners (Tobian 
et al. 2010). If there is a 60% protection against HIV-1 acquisition conferred through 
circumcision, conversely, it means it is not effective in 40% of men. There has been 
speculation that the route of HIV-1 entry may be through the epithelium of glans and 
the urethral opening in the penis. It is difficult to obtain fresh samples of these areas 
in order to study these tissues, however more research into these areas needed to 
determine the possible HIV-1 target cells present and their role in HIV-1 acquisition. 




adolescents, therefore circumcision in adolescents aged 14-24 is of utmost importance 
as this particular population of boys and young men are at a higher risk of a STI due 
to their sexual activities, this in turn may elevate their risk of HIV-1 acquisition and 
transmission. A study profiling the humoral response in the penis demonstrated that 
local and systemic antibodies contribute to the foreskin immune response and that 
there was selective antibody isotype penetration to the foreskin epidermis, particularly 
at the inner foreskin (Lemos et al. 2015). These findings may contribute to vaccine 
studies that have a protective effect against STIs (Lemos et al. 2015). Discussing 
sexual intercourse is to a certain degree a taboo topic amongst many societies in 
southern Africa, the practice of circumcision and knowledge about STIs and HIV-1 
may impact safer sexual practices. Circumcision in this group of young men can 
decrease the risk of contracting and transferring STIs as well as provide a protective 
effect against the acquisition of HIV-1, thereby lowering the prevalence of HIV-1 in this 
vulnerable group of young men.  
This dissertation has examined some immune properties of the foreskin from young 
males aged 14-24 years who elected to undergo medical male circumcision. It is 
known that boys in this group demonstrate biological and psychosocial changes such 
as puberty and social development that take place and will affect the lives of these 
adolescents and signifies the move from childhood to adulthood (UNAIDS/UNICEF 
2015). AIDS is the leading cause of death among adolescents in Africa with 120 000 
deaths in adolescents in 2013 and the second most common cause of death among 
adolescents around the world (UNAIDS/UNICEF 2015). This is also the age of many 
adolescents’ sexual debut and engagement in risky sexual behaviour such as multiple 
sexual partners, sexual intercourse while under the influence of drugs or alcohol and 
having unprotected sex (Shisana, O, Rehle, T, Simbayi LC, Zuma, K, Jooste, S, Zungu 
N, Labadarios, D, Onoya 2014). There are currently only 24.3% in this age group that 
have knowledge about HIV-1 transmission and prevention in South Africa (Shisana, 
O, Rehle, T, Simbayi LC, Zuma, K, Jooste, S, Zungu N, Labadarios, D, Onoya 2014). 
The aim of this thesis was to optimise the techniques used to determine the type of 
immune cells present in the foreskin by flow cytometry and immunofluorescence so 
that the impact of an asymptomatic STI on the numbers of immune cells present in the 




In Chapter 2, as part of method development, we optimised a protocol to isolate viable 
cells from the foreskin of men. We found that the use of fresh tissue with collagenase 
A at a concentration of 500U/ml to digest the foreskin tissue and the use of scissors 
to macerate the foreskin tissue was best suited to liberate and isolate viable cells. A 
major limitation to the optimisation was the limited availability of resources such as the 
medimachine which was brought to our lab as a demo and the low viability of cells 
retrieved from frozen samples. It was therefore not possible to repeat experiments in 
triplicate as there was limited time in which to use the machine. Flow cytometry 
analysis on all the samples was not possible due to the low amount of viable cells 
isolated from foreskin tissue in stored samples. Furthermore, flow cytometry analysis 
was limited due to lack of fresh foreskin samples available after optimisation of the 
foreskin cell isolation method. Therefore, an accurate comparison using fresh 
compared to frozen tissue to isolate viable cells from the foreskin tissue was not 
possible. For future considerations, these experiments should be performed in 
triplicate on fresh samples received in the lab. A portion from the same fresh sample 
should be frozen and stored for a week before applying the same protocol to those 
samples.  
There were a few other limitations to this study, not all possible STIs were tested for 
and a subset of the cohort was tested for HPV. The effects of HPV alone could not be 
examined as the majority of the individuals with an HPV infection also had a STI. 
Furthermore, there were low DNA yields from swabs, therefore these samples were 
not tested for HPV and lastly, it was not feasible to test for HPV in all of the individuals. 
Individuals with other asymptomatic STIs such as syphilis, hepatitis A, B and C may 
have had an influence on the number of HIV-1 target cells present in the foreskin. 
Foreskins from the EDH site arrived within 24 hours of circumcision, the delay in 
processing of the foreskin sample may have had potential effects such a degration of 
enzymes and change in genes (Grizzle et al. 2010). We did not investigate 
comparisons in transportation time, however, we were aware that any optimisation of 
Flow cytometric methodology should be assessed using the 2 h samples from the 
Johannesburg site.  For the IHC results, all data were generated using the 24 h 
samples from the Edendale site. Furthermore, in order to determine the effects of 
collagenase digestion on cytokine profile, it would be best to compare the various 




images using IHC was limited to two colours as we were only able to use the red and 
blue lasers. Optimisation for CCR5 was only possible using cell lines (M4T, GXR) and 
a few tissue samples from participants. Furthermore, due to time constraints and 
CCR5 antibody availability, CCR5 staining was not extended to the subset of 
participants. The staining is currently being carried out by collaborators at 
Northwestern University in Chicago. IHC staining was not done blinded, i.e. tissue site 
(inner/outer) and participant status (STI+/-) was known and this could have introduced 
bias. The sample size may not be indicative of the prevalence of STIs in this 
community. Although an average of five images were taken per tissue at widely 
distributed positions per tissue section, this is not necessarily representative of the 
total size of the inner or outer foreskin. Each image taken had varying number of 
immune cells present in each tissue section, therefore imaging of the entire foreskin 
may reveal greater numbers of HIV-1 target cells in the foreskin. The drawing of the 
lines used to measure keratin thickness was by hand and not computer generated, 
regardless, human error cannot account for the median difference of 1.712µm found 
between the inner and outer foreskin.  
For future considerations, we should compare the tissue from the glans and urethra of 
a circumcised penis by use of tissue biopsies of the foreskin tissue to determine 
whether the foreskin truly enhances susceptibility to STIs and HIV-1 infection. The use 
of STI and HIV-1 negative tissue samples from individuals from these regions can be 
used and infected with different types of STIs and HIV-1 using a model to culture the 
different types of tissue using a transwell method similar to that by Ganor et al., The 
amount and type of immune cells infected can then be quantified in each type of tissue 
to determine which type of tissue is more susceptible to infection with a STI and HIV-
1. Next, investigate the tissues with different types of STIs (that was previously 
infected) by infecting them with HIV-1 using the same model in order to determine the 
impact of HIV-1 acquisition in the presence of STIs by quantifying the amount of 
immune cells infected with HIV-1. This would help evaluate the effect of STIs and HIV-
1 on the number of cells infected, effect of different STIs on HIV-1 acquisition, the role 
of the keratin layer in the inner and outer foreskin and whether the glans, foreskin or 
urethral tissue is more susceptible to infection. Furthermore, the characterisation of 
different subsets of potential target cells in the different types of tissue should be 




increases infectivity. However, this method would be difficult as fresh tissue samples 
from the glans and urethra of the penis would be difficult to obtain. Samples should be 
transported to the lab within 4 hours of circumcision and all experiments should be 
conducted on fresh tissue as far as possible. The three randomised control trials that 
were conducted in SA showed circumcision reduced HIV-1 acquisition in heterosexual 
males regardless of surgical procedure (Tobian et al. 2010), although MMC methods 
should be standardised in studies as well sites where the study is being conducted.  
 A bigger sample number and complete screening for asymptomatic STIs should be 
included when recruiting patients. A study conducted in the Gauteng province in South 
Africa on the quality of STI case management services found that general knowledge 
about STIs was sub-optimal among providers without STI training (Ham et al. 2016). 
The findings by Ham et al indicated that the responses about STI case management 
did not meet standards by WHO and South African Department of Health (SADH). 
This highlights the need for additional STI education and training in this department. 
Lastly, although screening for asymptomatic STIs is costly, it cannot be emphasized 
enough that South Africa revise their current treatment guidelines for STIs and include 
treatment of asymptomatic STIs in their syndromic STI management programmes.  
In conclusion, this study has contributed to research on the MGT in South Africa. 
Further optimisation of the foreskin cell isolation method is required in order to isolate 
a higher percentage of viable cells from the foreskin. The flow cytometry panel can 
then be expanded in order to identify the different types of immune cells that are 
present in the foreskin. The use of immunohistochemistry to determine the density and 
position of HIV-1 target cells in this study may be used to identify possible mechanisms 
of HIV-1 entry and infection in the foreskin. Triple stains using immunohistochemistry 
and imaging of entire sections of foreskin tissue at a time would allow for better 
quantification of the different types and position of immune cells present in the 
foreskin. Lastly, although this study did not test for all possible STIs, the treatment of 
asymptomatic STIs is needed as this study has shown the increased number of HIV-
1 target cells in STI+ compared to STI- participants. L. F. Johnson et al. 2011., 
estimated that more than 50% heterosexually transmitted HIV-1 in the early stages of 
the South African pandemic is owed to STIs. The syndromic management of STIs in 
South Africa has reduced the STI prevalence in both men and women (Johnson et al. 




may be driving inflammation and recruitment of cells to the foreskin, thereby increasing 
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Table S1: IDL algorithm and cell density formula applied to analyse images for 
immunohistochemistry 
Parameter Algorithm/Formula applied 
CD207Filaggrin tissue_measure, '*Maximumintensityprojection*.lsm', n=3, 
i=[1,1,0], d=[[1,0],[0,1],[2,0]], h=1, l=['K1', 'K2', 'LC'], ver=1 
CD4Ki67 tissue_measure, '*Maximumintensityprojection*.lsm', n=3, 
i=[1,0,0], d=[[1,0],[2,0]], h=1, l=['K', 'Ki67', 'CD4'], ver=1 
Cell Density *Nc/A; A= Ni x I1 x I2 x p2 
* Nc = number of cells; A = Area Surveyed; Ni = number of images;  I1 = y pixel size; I2 = x pixel size; p2 
= pixel size in µm squared  
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